Adult Medicine PRN

Awards

• Caitlin Gibson: Teaching and Mentoring Award, ACCP Education and Training PRN.
• Charles Seifert: 2023 Texas Tech University Health Sciences Center President’s Excellence in Team Teaching Award for Clinical Toxicology, Drug Abuse, & Patient Safety, Texas Tech University Health Sciences Center.
• Jennifer Szwak: Vizient Service Award, Vizient.

Grants

• Jon P. Wietholter: Working to develop a modular/integrated curricular revision at the University of Cape Coast School of Pharmacy & Pharmaceutical Sciences in Cape Coast, Ghana. Fulbright Specialist Grant. U.S. Department of State: Bureau of Educational Affairs.

Publications

• Meredith J, Anderson SL. Microlearning: bite-sized education for the busy healthcare professional. Almanac. Published September 5, 2023.
• Laws MB, Wahking R, Blackburn E, Williams W, Schadler A, Fritz MK. Outcomes in variceal bleeding associated with continuous octreotide in patients with delayed endoscopy. J Pharm Pract 2024 Jan 19. [Epub ahead of print]
• Bond R, Gibson CM, Talasaz AH, et al. Analysis of gender and race in pharmacy faculty administrative ranks. Am J Pharm Educ 2024;88:Article 100585.
• Hulsizer AL, Davis S, Gibson CM. Does emergency medical services blood collection shorten time to tissue plasminogen activator in ischemic stroke? J Pharm Tech 2023;39:195-8.
• Johnson HN, Micek ST, Teshome BF, et al. Evaluation of an individual examination remediation policy in a professional pharmacy course. Curr Pharm Teach Learn 2023;15:961-7.
• Seifert CF, Mahan RJ, Mathys M, et al. An evaluation of non-academic predictors of success in a doctor of pharmacy program. Am J Pharm Educ 2023;87:Article 8924.
• Bergman E, Armstrong C, Seifert CF. Evaluating the role of intravenous antihypertensive agents in falls of hospitalized patients. J Gen Med 2023;4:1-5.
• Yang SH, Seifert CF. Evaluation of bleeding in orthopedic surgery with perioperative use of serotonergic antidepressants. Ann Pharmacother 2023;57:885-91.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course. 2023 ed. American College of Clinical Pharmacy, 2023:83-113.
• Richter LM, Soric MM, Hilaire ML, et al. Integrating professional identity formation into experiential pharmacy education and training. Am J Health Syst Pharm 2024;81:e48-52.
• Szwak JA, Anwar Assadi R, Gonzalez J, Hong LT, Meyenburg LK, Miesner AR, Steuber T, Fritz MK. Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists. J Am Coll Clin Pharm 2024 Jan 2024. [Epub ahead of print]
• Mercer KJ, Craddock KE, Patel SV, Knoebel RW, Soni HP, Lourenco LM, Bastow SS, Szwak JA. Implementation of debriefing services for pharmacy residents in a 24-hour, in-house clinical pharmacy on-call program: a pilot study. J Pharm Pract 2023 Jun 15. [Epub ahead of print]

Presentations

• Sarah Anderson: Think again: challenging the path of least resistance. Presented at: CMEpalooza; October 18, 2023; virtual.
• Caitlin Gibson:
  • The next generation in anticoagulation: goodbye Gen-Xa, hello Gen XIa? Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • Updates in cardiology. Presented at: American College of Clinical Pharmacy Last-Chance Pharmacotherapy Review Webinar; September 2023; virtual.

• Haley Johnson: PSAP live: updates in endocrinology. Presented at: 2023 ACCP Annual Meeting; November 2023; Dallas, TX.
• Charles Seifert:
  • Virtual interprofessional education event with pharmacy and medical students: ethical dilemma case discussion within interprofessional practice. Presented at: 2023 ACCP Annual Meeting; November 14, 2023; Dallas, TX.
  • Impact of metformin on ischemic stroke events in type 2 diabetes with chronic kidney disease. Presented at: Alcalde Southwest Leadership Conference for Pharmacy Residents, Fellows, and Preceptors; April 20, 2023; Galveston, TX.
  • Evaluation of local prescribing patterns and antimicrobial resistance in acute pyelonephritis caused by E. coli. Presented at: Alcalde Southwest Leadership Conference for Pharmacy Residents, Fellows, and Preceptors; April 20, 2023; Galveston, TX.
  • Discharge prescribing practices of naloxone for high-risk patients in the emergency department. Alcalde Southwest Leadership Conference for Pharmacy Residents, Fellows, and Preceptors; April 20, 2023; Galveston, TX.
  • Ethical dilemma case discussion within interprofessional practice. Presented at: Texas Interprofessional Education Consortium; April 20, 2023; Houston, TX.

• Mate Soric: Study designs: design and application. Presented at: American College of Clinical Pharmacy Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course Webinar; October 2023; virtual.
• Jennifer Szwak: Use of telemedicine for asthma and COPD self-management among underserved populations. Presented at: CHEST Annual Meeting; October 2023; Oahu, HI.
• Jon P. Wietholter: Pharmacy education: new insights. Presented at: University of Cape Coast School of Pharmacy and Pharmaceutical Sciences; February 2024; Cape Coast, Ghana.

New ACCP Fellows

• T. Michael Farley
• Patrick J. Gallegos

Ambulatory Care PRN

Promotions

• Sara (Mandy) Reece: Professor, PCOM Georgia School of Pharmacy.
• Christy Sherrill: Teaching Associate Professor, UNC Eshelman School of Pharmacy, Asheville Campus.
• Caressa Trueman: Assistant Residency Program Director, Nebraska Medicine’s PGY2 Ambulatory Care Pharmacy Residency Program.

Awards

• Helen (Nellie) Berlie: Outstanding Reviewer, Pharmacotherapy.
• Abigail Elmes:
  • Pharmacy Practice 2023 Publication of the Year Award, University of Illinois Chicago College of Pharmacy.
  • First Place, Poster Walk Rounds ACCP Annual Meeting, Ambulatory Care PRN.
  • Second Place, Outstanding Paper Award, ACCP Ambulatory Care PRN.
  • Frederick P. Siegel Innovative Teaching Award, University of Illinois Chicago College of Pharmacy.

• Nada Farhat: Fred W. Arnold Public Relations Award, Michigan Pharmacists Association.
• Paige Gundrum: OAK Award, SSM Health.
• Sara Lingow: Phi Lambda Sigma Honorary Member. Phi Lambda Sigma, Alpha Theta Chapter at St. Louis College of Pharmacy.
• Sharmon P. Osae: Member of the Year, 2023 Ambulatory Care PRN Member of the Year.

Grants

• Abigail Elmes: University of Illinois Chicago Center for Clinical and Translational Science Pilot Implementation Grant. Principal Investigator ($29,968).
• Sharmon P. Osae: PCP HELPR Primary Care Provider Healthcare Extensions by Leveraging Pharmacists in Rural Communities Through Telehealth Technologies; President Morehead’s 2023 Interdisciplinary Seed Grant Program at the University of Georgia. Co-Investigator ($59,502.60).
• Christy Sherrill: Development and Implementation of a Web-Based Escape Room with Embedded Principles of Pharmacist Independent Prescribing. PharmAlliance Early Career Researcher Award. Principal Investigator ($10,000).

Publications

• Ashjian EJ, Clarke MN, Pogue KP. Overview of finerenone and its role in the treatment of chronic kidney disease in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2023;80:1708-21.
• Ashjian EJ, Genereaux M, Thompson AN, et al. Transitioning from points-based grading to a modified pass/fail grading approach in a simulated patient program. Am J Pharm Educ 2024;88:100645.
• Bartelme KM. Polycystic ovary syndrome. In: O’Connell M, Smith JA, Borgelt LM, eds. Women’s Health Across the Lifespan, 3e. McGraw-Hill, 2024. Available via Access Pharmacy.
• Moore HE, Zaya V, Burns CV, Berlie HD. Accidental once-daily use of dulaglutide: a case report. Clin Diabetes 2024 Jan 12. [Epub ahead of print]
• Infante A, Elmes AT, Petzel Gimbar R, et al. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement. Int J Drug Pol 2024;124:104323.
• Jarrett JB, Bratberg J, Burns, Cochran G, DiPaula BA, Dopp AL, Elmes AT, et al. Research priorities for expansion of opioid use disorder treatment in the community pharmacy. Subst Abuse 2023;44:264-76.
• Hutchison RW, Carhart J. Opioid and benzodiazepine utilization patterns in metropolitan and rural Texas. J Opioid Manag 2023;19:433-43.
• Jurga T. Secondary hypertension. In: Jackevicius CA, Patterson JH, eds. Cardiology Self-Assessment Program Book 2: Blood Pressure Disorders and Practice Management Secondary Hypertension. ACCP/ASHP, 2023:81-98.
• Dedo R, Jurga T, Barkham J. VA home telehealth program for initiating and optimizing heart failure guideline-directed medical therapy. Fed Pract 2023;40:S16.
• Lingow S, Jeon M, Richter SK. Evaluation of student peer- and self-grading in an integrated pharmacotherapy course. Am J Pharm Educ 2023;87:100618.
• Lobkovich A, Javeed S, Habhab A, Hammoud R, Lipari M. Pharmacist perceptions of delivering patient care through telehealth. Am J Health Syst Pharm 2024 Jan 31. [Epub ahead of print]
• Wheeler SE, McDanel D, Kiser K, Majerczyk D, Nguyen J, Crannage E, Smith T, Lipari M. Essential elements for a nationwide remote pharmacy trainee mentoring program: an opinion of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm 2024 Jan 11. [Epub ahead of print]
• Mukherjee SM, Dawson A, Carey KM. Preconception care for individuals with diabetes. EMJ 2023;11:92-101.
• Harris IM, Hilaire ML, Jeon M, Kier KL, Munir F, Carmon AS, Maffei MV, Mukherjee SM, Osae SP. Commentary: Pharmacists’ role in combating the medical misinformation epidemic. J Am Coll Clin Pharm. [In press]
• Miller JA, Lavender DL, Johnson BR, Osae SP, et al. Factors associated with pharmacy residency matching: a scoping review. J Am Coll Clin Pharm 2023;6:171-85.
• Rawal S, Osae SP, Tackett RL, et al. Community pharmacists’ naloxone counseling: a theory-informed qualitative study. J Am Pharm Assoc. [In press]
• Whitten S, Phillips BB, Osae SP, et al. Factors associated with attaining a pharmacy residency interview: a scoping review. J Am Coll Clin Pharm. [In press]
• Schumacher C, Chorpash A, Bolch C, et al. Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors. Pharmacotherapy 2024;44:249-57.
• Sherrill CH, Hwang AY. The pursuit of optimal semaglutide dosing in type 2 diabetes continues. Lancet 2023;402:668-9.
• Sherrill CH, Hwang AY. Use of cardioprotective antidiabetic medications in adults with and without cardiovascular disease, 2015 to March 2020. Ann Pharmacother 2024;58:248-54.
• Bickenbach E, Keegan CL, Brockel MC, Mast OG, Ghantae A, Hwang AY, Sherrill CH. Changes in metabolic parameters of hemoglobin A1c, weight, and blood pressure during and after COVID-19 stay-at-home orders in North Carolina. J Am Board Fam Med 2024 Jan 25. [Epub ahead of print]
• Bradley CL, McMillin SM, Hwang AY, Sherrill CH. Reply: Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2024 Jan 21. [Epub ahead of print]
• Krichbaum M, Fernandez D, Singh-Franco D. Barriers and best practices on the management of opioid use disorder. J Pain Palliat Care Pharmacother 2024;38:56-73.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course. 2023 ed. American College of Clinical Pharmacy, 2023:83-113.
• Richter LM, Soric MM, Hilaire ML, et al. Integrating professional identity formation into experiential pharmacy education and training. Am J Health Syst Pharm 2024;81:e48-52.
• Wheeler SE, McDanel D, Kiser K. Essential elements for a nationwide remote pharmacy trainee mentoring program: an opinion of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy. JACCP 2024 Jan 11. [Epub ahead of print]
• White S. Identifying the role of Janus kinase inhibitors for the treatment of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. [In press]

 Presentations

• Kate Cozart:
  • We DID start the fire: igniting motivation in pharmacy learners. Presented at: 2023 ACCP Annual Meeting; November 2023; Dallas, TX.
  • The art and science of compassion. Presented at: ASHP Midyear; December 2023; Anaheim, CA.

• Abigail Elmes:
  • Providing medication-assisted recovery via low barrier buprenorphine from a mobile medical unit in Chicago: a two-year review. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.
  • Internal medicine and emergency medicine provider perceptions of a pharmacist-driven opioid use disorder medication-assisted recovery inpatient consult service. Presented at: 2023 ACCP Annual Meeting; November 2023; Dallas, TX.
  • Pharmacist-driven inpatient opioid use disorder medication assisted recovery (OUD MAR) consult service: a year in review. Presented at: 2023 ACCP Annual Meeting; November 2023; Dallas, TX.

• Ellen Jones: How do I adapt the guidelines, yet individualize my patient’s care? Presented at: Hong Kong Pharmacy Conference; February 2024; Hong Kong, China.
• Sara Lingow: Weighing the options: updates on the management of persons with overweight or obesity. Endocrine and Metabolism PRN Focus Session. Presented at: 2023 ACCP Annual Meeting; November 2023; Dallas, TX.
• Sharmon P. Osae: Keynote Address: Understanding social determinants of health and how they relate to pharmacy and innovation. West Virginia Pharmacists Association 2023 Annual Meeting; October 2023; Roanoke, WV.
• Christie Schumacher:
  • Managing chronic kidney disease in patients with diabetes. Presented at: South Piedmont AHEC 26th Annual Procrastinators Marathon: Hot Topic Updates in Pharmacy.
  • Association of Diabetes Care and Education Specialists Live Webinar: Advances in diabetes and cardiometabolic care.
  • Association of Diabetes Care and Education Specialists Live Webinar: Use of diabetes medications in the management of non-diabetes conditions.

• Mate Soric: Study designs: design and application. American College of Clinical Pharmacy Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course Webinar; October 2023; virtual.
• Shannon White: The expertise of the specialty pharmacist in pediatric eosinophilic esophagitis. Presented via: Pharmacy Times Continuing Education; December 2023.

Other Notable Achievements

• Sarah Amering: 2024 President-Elect, New York ACCP Chapter.
• Magaly Rodriguez de Bittner: Slated as President-Elect candidate for the American Pharmacists Association.
• Alissa R. Segal: Serving second year of appointment on the American Diabetes Association Professional Practice Committee (which annually updates the ADA Standards of Care).

Cardiology PRN

Awards

• Arden Barry: Pharmacotherapy Outstanding Reviewer.
• Caitlin Gibson: ACCP Education & Training PRN Teaching and Mentoring Award.
• Angela Shogbon Nwaesei: ACCP Education Award.
• J. Herbert Patterson: ACCP Robert M. Elenbaas Service Award.
• Kristin Watson: JACCP Outstanding Reviewer.

Grants

• Jim Coons: Pharmacogenomics Education and Training (Test2Learn). Veterans Health Administration ($513,750).

Publications

• Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt L, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik J, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation; a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024;149:e1-e156.
• Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt L, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik J, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation; a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2024;83:109-279.
• Baker WL, Roberts MS, Bessada Y, et al. Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review. Curr Med Res Opin 2023;39:1183-94.
• Bozkurt B, Ahmad T, Alexander KM, Baker WL, et al.; Writing Committee Members. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail 2023;29:1412-51.
• Jaiswal A, Kittleson M, Pillai A, Baran D, Baker WL. Usage of older donors is associated with higher mortality after heart transplantation: a UNOS observational study. J Heart Lung Transplant 2024 Jan 15. [Epub ahead of print]
• The ACCP Research Affairs Committee: Murphy JE, Hennessey E, Azad A, Barreto J, Coons E, Coons JC, Gill SK, Goodlet K, Jennings D, et al. Best practices in pharmacy resident research and quality improvement projects. J Am Coll Clin Pharm 2024;7:75-84.
• Foster EM, Sullinger D, Coons JC. Management considerations for pulmonary arterial hypertension pharmacotherapy in the intensive care unit. Pharmacy (Basel) 2023;11:145.
• Bond R, Gibson CM, Talasaz AH, Van Tassell B. Analysis of gender and race in pharmacy faculty administrative ranks. Am J Pharm Educ 2024;88:Article 100585.
• Hulsizer AL, Davis S, Gibson CM. Does emergency medical services blood collection shorten time to tissue plasminogen activator in ischemic stroke? J Pharm Tech 2023;39:195-8.
• Hale G, Marcellus V, Benny T, et al. Real-world analysis of long-acting and NPH-containing insulins on glycemic control. Sr Care Pharm 2024;39:42-9.
• Hale G, Puchades E, Jacomino G, et al. Use trends of chlorthalidone and hydrochlorothiazide among US adults with hypertension: NHANES 2009–2018. J Hypertension 2024;42:490-6.
• Ali US, Hale GM, Santibañez M, et al. Is now our time? History to provider status for allied health professions and the path for pharmacists. J Am Pharm Assoc (2003). 2023;63:1515-20.
• Arce L, Hale G, Khanfar N, et al. Earthquakes, hurricanes, pandemics: pharmacy students impacting pharmacy practice in Puerto Rico through medication therapy management services during natural disasters. Disaster Med Public Health Prep 2024;18:1-4.
• Bruns BE, Lorenzo-Castro SA, Hale GM. Controlling blood pressure during a pandemic: the impact of telepharmacy for primary care patients. J Pharm Pract 2024;37:364-8.
• Davis DD, Hale G, Moreau C, et al. Evaluating pharmacist-driven interventions in a primary care setting to improve proportion of days covered and medication adherence. J Pharm Pract 2024;37:27-34.
• Lopez NA, Kerelos T, Hale G. The impact of pharmacists on telehealth during transitions of care: a literature review. J Pharm Pract 2023;36:1225-31.
• Lugo Zamora IL, Lloyd C, Lorenzo-Castro S, Mussenden C, Hale G. Utilizing pharmacist-led telehealth services in ambulatory patients with heart failure. Innov Pharm 2023;14:1-4.
• Pham H, Gangoo-Dookhan T, Hale G, et al. Impact of student pharmacist–led transition-of-care services on 30-day hospital readmissions at a university call center. J Pharm Tech 2023;39:207-11.
• Akioyamen LE, Abdel-Qadir H, Han L, Sud M, Mistry N, Alter DA, Atzema CL, Austin PC, Bhatia RS, Booth GL, Dhalla I, Ha ACT, Jackevicius CA, et al. Association of neighborhood-level marginalization with healthcare use and clinical outcomes following hospital discharge in patients who underwent coronary catheterization for acute myocardial infarction in a single-payer healthcare system. Circ Cardiovasc Qual Outcomes 2023;16:e010063.
• Bobrowski D, Dorovenis A, Abdel-Qadir H, McNaughton CD, Alonzo R, Fang J, Austin PC, Udell J, Jackevicius CA, et al. Association of neighborhood-level material deprivation with adverse outcomes and processes of care among patients with heart failure in a single-payer healthcare system: a population-based cohort study. Eur J Heart Fail 2023;25:2274-86.
• Lauffenburger JC, Jackevicius CA. Complex picture of prescription drug discount programs and out-of-pocket costs in cardiovascular disease. Circ Cardiovasc Qual Outcomes 2023;10:e010329.
• Moon J, Ozaki AF, Chong A, Sud M, Fang J, Austin PC, Ko DT, Jackevicius CA. Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes. Pharmacoepidemiol Drug Saf 2024;33:e5704.
• Ton I, Moon J, Sengul A, Mody FV, Rahman T, Han JK, Jackevicius CA. Evidence-based cardiovascular disease medicines’ availability in low-cost generic drug programs in the United States: a cross-sectional study. Ann Intern Med 2023;176:1190-9.
• Verma A, Fonarow GC, Hsu JJ, Jackevicius CA, et al. The Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: a pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction. Circ Heart Fail 2023;16:e010278.
• Rockhold M, Kunkel L, Lacoste JL, Szymanski T, et al. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia. J Vasc Surg 2024 Jan 24. [Epub ahead of print]
• Schumacher C, Chorpash A, Bolch C, et al. Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors. Pharmacotherapy 2024;44:249-57.
• Amarh E, Tisdale JE, Overholser BR. Prolonged exposure to remdesivir inhibits the human ether-a-go-go-related gene potassium current. J Cardiovasc Pharmacol 2023;82:212-20.
• Carpenter JS, Fagan R, Alzahrani M, Jaynes HA, Tisdale JE, et al. “Quick flutter skip”: midlife women’s descriptions of palpitations. Menopause 2023;30:1014-21.
• Chong S, Huynh B, Wong S, Woldeyesus T, Faulks M, El-Amin K, Thibeaux J, Lewis J, Harlin R, Carter M, Shatara R, Zhou C, et al. Preferences and perspectives of Black male barbershop patrons on receiving health care in nontraditional settings. Health Equity 2023;7:835-42.

New ACCP Fellows

• Danielle Blais
• Kate Cabral
• Patrick Gallegos
• Kazuhiko Kido
• Daniel Majerczyk

Other Notable Achievements

• Rachel Klosko:
  • NYS ACCP President, Binghamton University School of Pharmacy and Pharmaceutical Sciences.
  • New York Society of Health-System Pharmacists – Southern Tier Chapter President Elect, Binghamton University School of Pharmacy and Pharmaceutical Sciences.

Central Nervous System PRN

Promotions/New Positions

• Emily Laswell: Promoted to Professor of Pharmacy Practice at Cedarville University, Cedarville, OH.

Publications

• Bishop JR, Schneiderhan ME, Butler T, et al. Pharmacogenomics to support mental health medication therapy management: clinical practice considerations and a conceptual framework to enhance patient care. J Am Coll Clin Pharm 2024;7:160-70.
• Yu JRT, Sokola BS, Walter BL. Optimization of inpatient medication administration among persons with Parkinson’s disease: recommendations on pharmacy technology and workflow. Front Pharmacol 2023;14:1254757.

Presentations

• Jeffrey R. Bishop:
  • Insights and perspectives on the 2023 CPIC serotonin reuptake inhibitor antidepressant practice guideline. Presented at: American College of Clinical Pharmacy PK/PD/PG PRN and the University of Minnesota Pharmacogenomics ECHO special topic presentation; November 3, 2023; virtual.
  • Pharmacogenetic guideline updates and resources to support evidence-based implementation. Presented at: 2023 American Academy of Child and Adolescent Psychiatry Annual Meeting; October 26, 2023; New York, NY.
  • Genomic and blood-based biomarker studies of psychotic disorders: mechanistic insights and clinical implications. Presented at: 2023 West China International Forum for Schizophrenia research; October 20, 2023; Chengdu, China.

• Ronald C. Reed: Evidence for a between-sex anti-seizure medicine (ASM) efficacy difference: males respond better than females, as evidenced by valproate (VPA) suppression of EEG photoparoxysmal response (PPR). Presented at: 35th International Epilepsy Conference (IEC); September 2-6, 2023; Dublin, Ireland.

New ACCP Fellows

• Ian McGrane
• Richard Silvia

Clinical Administration PRN

Publications

• Parrish RH II. In response to: Multicomponent pharmacist intervention did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants. J Gen Intern Med 2024 Jan 5. [Epub ahead of print]
• Parrish RH II (as part of the Enhanced Recovery Comparative Pharmacotherapy Collaborative). Effect of pharmacoprophylaxis on postoperative outcomes for elective colorectal surgery: a multi-center retrospective cohort study within an enhanced recovery after surgery framework. Healthcare (Basel) 2023;11:3060.
• Parrish RH II, Powers BK, Ponder HL, et al. Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and comparison of guidelines for perioperative pharmacotherapy core items. World J Surg 2024 Feb 13. [Epub ahead of print]
• Sikand H (as part of the 2023 ACCP Research Affairs Committee). Best practices for supporting and improving pharmacy resident research and quality improvement projects. J Am Coll Clin Pharm 2024;7:75-84.

Presentations

• Richard Parrish II:
  • Pharmacoprophylaxis in colorectal surgery: a causal model with latent variables. Presented at: 2023 ACCP Annual Meeting; November 10–14, 2023; Dallas, TX.
  • Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and synthesis of guidelines for perioperative pharmacotherapy elements. Presented at: 2023 ACCP Annual Meeting; November 10–14, 2023; Dallas, TX.

Other Notable Achievements

• Richard Parrish II:
  • Member, Pharmacy Health Informatics Technology Collaborative, Work Group 4, Pharmacist Guidance Manual for Systems Interoperability, 2023 – present.
  • Member, Centers for Medicare & Medicaid Services, PACIO Transitions of Care Project, 2023 – present.

Community-Based PRN

The Community-Based PRN thanks its past leadership, who have helped bring about the opportunity to connect community practitioners and researchers within ACCP and build the network. As the PRN starts its third year, we are excited to help uplift the clinical power of community-based pharmacists and the transformation occurring to improve patient care.

Promotions

• Christopher Daly: Clinical Associate Professor, University of Buffalo College of Pharmacy.

Awards

• Sophia Herbert: Distinguished New Practitioner Award, American Pharmacists Association.

Grants

• Jenni Bacci:
  • Partnering with Community Pharmacies to Enhance Access to Long-Acting Injectable Antipsychotics (LAIAs) in Washington State. Garvey Institute for Brain Health Solutions. Faculty Mentor/Co-Investigators.
  • Developing a Model of Care for Medications for Opioid Use Disorder at Community Pharmacies. Community Pharmacy Foundation. Principal Investigator.

Publications

• Bacci JL, Pollack SW, Skillman SM, et al. Impact of the COVID-19 pandemic on the community pharmacy workforce. Med Care Res Rev 2024;81:39-48.
• Zaraa S, White HS, Stergachis A, Protos C, Simic G, Bacci JL. Using design thinking to reimagine the community pharmacist’s role in epilepsy care. Epilepsy Behav 2024;150:109542.
• Carroll JC, Herbert SMC, Nguyen TQ, et al. Vaccination equity and the role of community pharmacy in the United States: a qualitative study. Vaccine 2024;42:564-72.
• Miran NK, DeLor B, Baker M, Fakhour J, Metz K, Huskey E, Kilgore P, Fava J. Vaccine administration by pharmacy technicians: impact on vaccination volume, pharmacy workflow and job satisfaction. Explor Res Clin Soc Pharm 2023;13:100397.
• Finke JB, Dorval E. Independent pharmacies and test and treat enhanced service. Florida Pharmacy Today, January 2024.
• Lingow S, Jeon M, Richter S. Evaluation of student peer- and self-grading in an integrated pharmacotherapy course. Am J Pharm Educ 2023;87:100618.

Presentations

• Jenni Bacci:
  • Bacci J, English C. Prescribing change: shaping tomorrow’s pharmacy workforce in Washington state. Presented at: Washington State Pharmacy Association Annual Meeting; November 2023; Cle Elum, WA.
  • Bacci JL. Community pharmacist intervention to close statin gaps in diabetes care: the GuIDE-S study. Presented at: Virgina Commonwealth University Center for Pharmacy Practice Innovation seminar series; September 2023; virtual.

• Fava J. Immunization update 2024. Presented at: Michigan Pharmacists Association; February 23, 2023; Detroit, MI.
• Jessica B. Finke:
  • PharmTalk: Innovative pharmacy practice models – an integrated test and treat enhanced pharmacy service model. Presented at: American Pharmacists Association Annual Meeting and Exposition; March 2024; Orlando, FL.
  • Early post-graduate panel. Presented at: National Community Pharmacists Association Annual Convention and Expo; October 2023; Orlando, FL.
  • Evaluating health literacy and HPV immunization rates amongst college students while implementing student pharmacist led clinics. Presented at: American Pharmacists Association Annual Meeting and Exposition; March 2024; Orlando, FL.
  • Resources needed to implement clinical programs within a nationwide clinically integrated network. Presented at: National Community Pharmacists Association Annual Convention and Expo; October 2023; Orlando, FL.

• John C, Gonchar Y, Kim J, Harris E, Jeon M. Determining patient preferences in switching between oral to long-acting injectable antipsychotics within the community pharmacy setting. Poster presented at: ASHP Midyear Meeting; December 2023; Las Vegas, NV.
• Jones E. How do I adapt the guidelines, yet individualize my patient’s care? Presented at: Hong Kong Pharmacy Conference; February 25, 2024; Hong Kong, China.
• Rebecca Lahrman:
  • Lahrman R. Preparing for winter: RSV vaccines and cold self-care. Presented at: Ohio Pharmacists Association; November 5, 2023; Columbus, OH.
  • Lahrman R. PharmTalk: The power of interprofessional collaboration – bring providers into the community pharmacy: interprofessional experiential education. Presented at: American Pharmacists Association Annual Meeting and Exposition; March 2024; Orlando, FL.

• Oshitari D, Luder H, Fava J. Diagnosis codes included on prescriptions transmitted to chain community pharmacies: a retrospective analysis. Poster presented at: American Pharmacists Association Annual Meeting; March 23, 2024; Orlando, FL.

Other Notable Achievements

• Jessica B. Finke:
  • Appointed Associate Director of PGY-1 Community-based Pharmacy Residency Program (CPRP), Palm Beach Atlantic University, Llyod L. Gregory School of Pharmacy.
  • Appointed Community Pharmacy Enhanced Services Network (CPESN) Florida – Other Network Luminary.

Critical Care PRN

Promotions

• Eden Brewington: Critical Care Clinical Pharmacist (Medical Intensive Care Unit), UK Healthcare-Good Samaritan Hospital, Lexington, KY.
• Vikas Gupta: Sr. Director, Clinical Pharmacy, Blue Health Intelligence, Chicago, IL.
• Leslie Hamilton: Professor, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN.
• Neha Naik: Clinical Pharmacy Coordinator-Critical Care and Cardiology, Emory University Hospital, Atlanta, GA.
• Alyssa Polotti: Emergency Medicine/Trauma Clinical Pharmacy Specialist, Trinity Health-St. Mary Medical Center, Langhorne, PA.

Awards

• Sarah Blackwell: 2023 Health System Pharmacist of the Year, Alabama Society of Health-System Pharmacists.
• Scott Bolesta: 2023 Publication of the Year, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Paige Bradshaw:
  • SCCM Ohio Chapter Critical Care Training Program of the Month – UCMC PGY-2 Critical Care, Society of Critical Care Medicine.
  • SCCM Surgery Section Congress Travel Grant Scholarship, Society of Critical Care Medicine.

• Jennifer Cole:
  • ASHP Preceptor of the Year, American Society of Health-System Pharmacists Foundation.
  • ASHP Literature Award Innovation in Pharmacy Practice Research, American Society of Health-System Pharmacists Foundation.

• Jessica Elefritz: Ohio Chapter of SCCM Outstanding Member Award, Society of Critical Care Medicine Ohio Chapter.
• Alexander Flannery: Kentucky Society of Health-System Pharmacists Literature Contribution Award, Kentucky Society of Health-System Pharmacists.
• David Gutenschwager: 2023 Resident/Fellow Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Anthony W. Hawkins:
  • Faculty Achievement in Classroom Teaching (FACT) Award, University of Georgia College of Pharmacy.
  • 2023 Education Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
  • Outstanding Mentor of the Year, Georgia Society of Health-System Pharmacists.

• Leslie Hamilton:
  • 2023 P3 Professor of the Month Award, University of Tennessee Health Science Center College of Pharmacy.
  • 2023 University of Tennessee Health Science Center Teaching and Learning Center Scholarship of Teaching and Learning Award.

• Judith Jacobi:
  • Presidential Citation, Society of Critical Care Medicine.
  • Glycemic Guideline Author Plaque, Society of Critical Care Medicine.

• Kelli Keats: 2023 Junior Investigator of the Year Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Jerika Nguyen: Presidential Citation, Society of Critical Care Medicine.
• Megan Rech:
  • 2025 EM Lifelong Learning and Self-Assessment (LLSA) Reading List, American Board of Emergency Medicine.
  • 2023 Emergency Medicine Practice and Research Network Mentor of the Year Award, American College of Clinical Pharmacy.
  • 2023 Mentor of the Year Award, Pharmacy to Dose: The Critical Care Podcast

• Andrea Sikora: 2023 Research Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Andrea Sikora and the MRC-ICU Investigator Team: 2023 Publication of the Year, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Susan Smith:
  • 2024 JACCP Outstanding Reviewer, Pharmacotherapy Publications, Inc.
  • Silver SCCM Snapshot Award, Society of Critical Care Medicine.

• Zach Smith: 2023 Mentor of the Year Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Joanna Stollings: 2023 Achievement Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.
• Heather Torbic: 2023 Clinical Practitioner Award, American College of Clinical Pharmacy Critical Care Practice and Research Network.

 Grants

• Rachel Klosko (Co-Investigator): Evaluating Barriers to Evidence-Based Use of Cardiorenal Protective Diabetes Medications in a Rural Population. Binghamton University SOPPS, Pharmacy Practice Research Pilot Program ($12,720).
• Susan Smith (Principal Investigator), Kelli Keats, Mojdeh Heavner, Andrea Sikora: Impact of Critical Care Pharmacy Board Certification on Quality of Care and Outcomes of Critically Ill Patients: A Planned Analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) cohort. Board of Pharmaceutical Specialties Grant ($5000).
• Susan Smith (Principal Investigator), Kelli Keats, Mojdeh Heavner, Andrea Sikora: American College of Clinical Pharmacy Critical Care Practice and Research Network. Multidisciplinary Research Network Grant.

Publications

• Rucci JM, Law AC, Bolesta S, et al.; from The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS). COVID-19 Registry Investigator Group. Variation in sedative and analgesic use during the COVID-19 pandemic and associated outcomes. CHEST Crit Care 2024;2:100047.
• Bolina J, Naik N, Shibu V, et al. 264: Phentolamine infusion for pheochromocytoma management in the setting of small bowel obstruction. Crit Care Med 2024;52:S107.
• Culshaw JR, Philpott C, Bradshaw PG, Reinstatler K, Brizzi M, Droege ME. Acute pain management in trauma patients on chronic buprenorphine therapy. J Surg Res 2023;289:27-34.
• Branan TN, Hawkins WA, Palmer R, Sikora A, Huntt K, Phillips BB, Clemmons AB, Bland CM, Smith SE. Translating clinical decision-making skills from a critical care pharmacy elective to the required curriculum. Am J Pharm Educ 2024;88:100599.
• Cole J. Carbapenem appropriateness in a rural facility: gap analysis and PEN-FAST for quality improvement. Infect Dis Clin Pract 2023;31:1-5.
• Cole J. Implementing preemptive, multi-gene pharmacogenomic testing in the inpatient setting: preliminary results from a small, rural facility. J Am Coll Clin Pharm 2024;7:207-14.
• Stark JE, Cole J. Evaluation of author instructions for inclusive language guidance in highly cited English language medical journals. J Gen Intern Med 2024;39:272-6.
• Oakley R, Al-Mahdi S, Guntschnig S, Trinh H, Custodio M, et al. Defining international critical care pharmacist contributions to sepsis and exploring variability. Curr Infect Dis Rep 2023;26:15-29.
• Banerjee O, Elefritz JL, Doepker BA, et al. Comparison of fixed dosing vs train of four titration of cisatracurium in COVID-19 ARDS patients. J Pharm Pract 2023 Dec 12. [Epub ahead of print]
• Booth JP, Aycock AC, Elefritz JL, et al. A resident-preceptor collaboration to encourage wellness and reduce burnout amongst pharmacy residents. Am J Pharm Educ 2023;87:100139.

• Magrum B, Elefritz JL, Eisinger G, et al. Efficacy of continuous infusion ketamine for analgosedation in the medical intensive care unit: a propensity-weighted analysis. J Pharm Pract 2023 Jul 22. [Epub ahead of print]
• Wiss AL, Doepker BA, Hoyte B, Olson LM, Disney KA, McLaughlin EM, Esguerra V, Elefritz JL. Impact of initial fluid resuscitation volume on clinical outcomes in patients with heart failure and septic shock. J Intensive Med 2023;3:254-60.

• Boldt D, Busse L, Chawla LS, Flannery AH, et al. Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States. Ren Fail 2023;45:2290932.
• Pandya K, Wiegand A, Behal M, Dempsey J, Olney B, Flynn J, Flannery AH, et al. The role of a pharmacy administration and leadership rotation within postgraduate year two critical care residency training. J Am Coll Clin Pharm 2023;6:1139-45.
• Patidar KR, Belcher JM, Regner KR, St Hillien SA, Simonetto DA, Asrani SK, Neyra JA, Sharma P, Velez JCQ, Wadei H, Nadim MK, Chung RT, Seethapathy R, Parada XV, Ouyang T, Ufere NN, Robinson JE, McLean Diaz P, Wilechansky RM, Przybyszewski EM, Smith TN, Ali AA, Orman ES, Schulz P, Siddiqui SM, Shabbir R, Liu LJ, Cama-Olivares A, Flannery AH, et al.; from the HRS-HARMONY consortium. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol 2023;79:1408-17.
• Chase AM, Forehand CC, Keats KR, Taylor AN, Jones TW, Sikora A. Evaluation of critical care pharmacist evening services at an academic medical center. Hosp Pharm 2024;59:228-33.
• Bauer KA, Puzniak L, Yu K, Klinker KP, Watts J, Moise P, Finelli L, Gupta V. Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 – October 2021). BMC Infect Dis 2023;23:490.
• Riccobene T, Ai CE, Yu KC, Gregory S, Kim B, Debabov D, Gupta V. Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa, including carbapenem-non-susceptible and multi drug resistant isolates: a multicenter analysis. Microbiol Spectr 2023;11:e03129-23.
• Yu K, Ye G, Edwards J, Dantes R, Gupta V, et al. Treated, hospital-onset Clostridioides difficile infection: an evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals. Infect Control Hosp Epidemiol 2024;45:48-56.
• Gutenschwager DW, Patel A, Soyad AT, Patel S, Szandzik EG, Kelly B, Smith ZR. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension center of comprehensive care. Am J Health Syst Pharm 2024;81:66-73.
• Hamilton LA, Kiles TM, Hohmeier KC. Black student perspectives to inform actionable steps toward diversity, equity, and inclusion in pharmacy residency programs. J Am Coll Clin Pharm 2023;6:96-102.
• Kiles TM, Hamilton LA, Hohmeier KC. “Following your dreams, not killing yourself to do so” – Black student perceptions of residency. Am J Pharm Educ 2023;87:100069.
• Leatherwood MS, Hamilton LA, Barber J, Rowe AS. Outcomes associated with levetiracetam use after spontaneous intracerebral hemorrhage. Neurohospitalist 2024;14:58-63.
• Harlan SS, Philpott CD, Keegan SP, Droege ME, Karve AS, Foreman B, Wakefield D, Mueller EW, Sangha K, Ngwenya LB, Courter JD, Desai P, Droege CA. Pharmacokinetics of levetiracetam seizure prophylaxis in severe traumatic brain injury. Ann Pharmacother 2023 Sep 30. [Epub ahead of print]
• Hawkins WA, Darley A, Malcom DR, Smith SE, Sikora A, Bland CM, Hixon LM, Flowers G, Branan TN. Design and implementation considerations of experiential interprofessional share days for a new practitioner. Am J Health Syst Pharm 2024;81:e12-e17.
• Branan TN, Hawkins WA, Palmer R, Sikora AN, Huntt K, Phillips BB, Clemmons AB, Bland CM, Smith SE. Translating clinical decision-making skills from a critical care pharmacy elective to the required curriculum. Am J Pharm Educ 2024;88:100599.
• He J, Gilbert BW, Cox TR. 956: Phytonadione utilization and the risk of bleeding in chronic liver disease. Crit Care Med 2024;52:S450.
• Gilbert BW, Murray DS, Cox TR, He J, et al. What are we waiting for? A review of early basal insulin therapy in diabetic ketoacidosis management. Am J Emerg Med 2023;72:147-50.
• Heavner MS, Louzon PR, Gorman EF, Landolf KM, Ventura D, Devlin JW. A rapid systematic review of pharmacologic sleep promotion modalities in the intensive care unit. J Intensive Care Med 2023;39:28-43.
• Fronrath MJ, Hencken L, Martz CR, Kelly B, Smith ZR. Fluid resuscitation and relation to respiratory support escalation in patients with and without pulmonary hypertension with sepsis. Pharmacotherapy 2024;44:61-8.
• Jacobi J, Kane-Gill S, Boucher B. Critical care pharmacists have a rich history and evolving roles. J Am Coll Clin Pharm 2023;6:934-41.
• Honarmand K, Sirimaturos M, Hirshberg EL, Bircher NG, Agus MSD, Carpenter DL, Downs CR, Farrington EA, Freire AX, Grow A, Irving SY, Krinsley JS, Lanspa MJ, Long MT, Nagpal D, Preiser JC, Srinivasan V, Umpierrez GE, Jacobi J. Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024: executive summary. Crit Care Med 2024;52:e161-e181.
• Nates JL, Oropello JM, Badjatia N, Beilman G, Coopersmith CM, Halpern NA, Herr DL, Jacobi J, et al.; Academic Leaders in Critical Care Task Force (ALCCM) of the Society of Critical Care Medicine. Flow-sizing critical care resources. Crit Care Med 2023;51:1552-65.
• Keats KR, Robinson R, Patel M, et al. Ascorbic acid for methemoglobinemia treatment: a case report and literature review. J Pharm Pract 2023 Jul 8. [Epub ahead of print]
• Keats KR, Sikora A, Heavner MS, Chen X, Smith SE. Optimizing pharmacist team-integration for ICU patient management (OPTIM): rationale, study design, and methods for a multi-centered exploration of pharmacist-to-patient ratio. Crit Care Explor 2023;5:e0956.
• Klosko RC, McGinley J, Rouhana N, et al. The Rural and Underserved Service Track (TRUST): a novel interprofessional, co-curricular program focusing on care for diverse underserved populations. J Interprof Educ Pract 2023;32:100632.
• Holder AL, Khanna AK, Scott MJ, Rossetti SC, Rinehart JB, Linn DD, et al. A Delphi process to identify relevant outcomes that may be associated with a predictive analytic tool to detect hemodynamic deterioration in the intensive care unit. Cureus 2023;15:e50169.
• Naik N, Hodges B, Robinson L, et al. 1257: Opioid shortage impact on critically ill patients. Crit Care Med 2024;52:S600.
• Naik N, Nguyen V, Maaty N, et al. 1493: Comparison of early versus late vasopressin initiation in septic shock. Crit Care Med 2024;52:S717.
• Caldwell L, Bhakta R, Naik N, et al. Comparison of low dose recombinant factor VIIa and 4-factor prothrombin complex concentrate for treatment of bleeding related to cardiac surgery. J Pharm Pract 2024 Jan 23. [Epub ahead of print]
• Mahmoud SH, Hefny FR, Panos NG, Delucilla L, Ngan Z, Perreault MM, Hamilton LA, Rowe AS, Buschur PL, Owusu-Guha J, Almohaish S, Sandler M, Armahizer MJ, Barra ME, Cook AM, Barthol CA, Hintze TD, Cantin A, Traeger J, Blunck JR, Shewmaker J, Burgess SV, Kaupp K, Brown CS, Clark SL, Wieruszewski ED, Tesoro EP, Ammar AA, Ammar MA, Binning MJ, Naydin S, Fox N, Peters DM Jr, Mahmoud LN, Keegan SP, Brophy GM. Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study. Pharmacotherapy 2023;43:279-90.
• Engstrom K, Brown CS, Mattson AE, Lyons N, Rech MA. Pharmacotherapy optimization for rapid sequence intubation in the emergency department. Am J Emerg Med 2023;70:19-29.
• Kiskaddon AL, Smith MM, Gilliland F, Rech MA. Pharmacist avoidance or reductions in medical costs in critically and emergently ill pediatrics: PHARM-PEDS study. Crit Care Explor 2023;5:e0980.
• Lawson CK, Faine BA, Rech MA, et al.; EMPHARM-NET Study Group. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: a systematic review. Am J Emerg Med 2023;77:158-63.
• Montgomery AJ, Litell J, Dang J, Flurin L, Gajic O, Lal A, Kuriyama A, Minami T, Takada T, Kusunoki M, Yoshino T, Otake T, Sato M, Norisue Y, Yokoyama T, Kawakami D, Nakataki E, Onodera M, Cartin-Ceba R, Portilla J, Melamed R, Sturgill JL, Vukoja M, Alhammad AM, Bissell BD, Daphtary K, Rech MA, et al. Digital Twin Platform for education, research, and healthcare delivery investigator group. Gaining consensus on expert rule statements for acute respiratory failure digital twin patient model in intensive care unit using a Delphi method. Biomol Biomed 2023;23:1108-17.
• Robinson A, Rech MA, DeChristopher PJ, et al. Defining the optimal calcium repletion dosing in patients requiring activation of massive transfusion protocol. Am J Emerg Med 2023;70:96-100.
• Tednes P, Marquardt S, Kuhrau S, Heagler K, Rech MA. Keeping it “current”: a review of treatment options for the management of supraventricular tachycardia. Ann Pharmacother 2023 Sep 24. [Epub ahead of print]
• Wang Y, Knobloch K, Lovett S, Lyons N, Rech MA. A pharmacist-driven deprescribing protocol for negative urine and sexually transmitted infection cultures in the emergency department increases antibiotic-free days. Am J Health Syst Pharm 2024;81:e83-e89.
• Rowe AS, Hamilton LA, Barber J, et al. Activated prothrombin complex concentrates for the treatment of factor Xa inhibitor associated spontaneous intracerebral hemorrhage. J Pharm Technol 2023;39:286-90.
• Orban JE, Ruckel C, Harlan SS. Concomitant andexanet alfa and 4F-PCC for factor Xa inhibitor associated intracranial hemorrhage. Clin Neurol Neurosurg 2023;233:107908.
• Ali US, Hale GM, Santibañez M, Berger K, Baldwin K. Is now our time? History to provider status for allied health professions and the path for pharmacists. J Am Pharm Assoc 2023;63:1515-20.
• Shoulders BR, Alexander KM, Allen JM, Voils SA, Feild CJ. Implementing innovative teaching strategies to promote student academic engagement in a critical care elective. J Am Coll Clin Pharm 2023;6:1022-9.
• Alshaer MH, Williams R, Mousa MJ, Alexander KM, Maguigan KL, Manigaba K, Maranchick N, Shoulders BR, et al. Cefepime daily exposure and the associated impact on the change in SOFA scores and vasopressors requirements in critically ill patients using repeated measures mixed-effect modeling. Crit Care Explor 2023;5:e0993.
• Venugopalan V, Maranchick N, Hanai D, Jimenez Hernandez Y, Joseph Y, Gore A, DeSear K, Peloquin CA, Neely M, Felton T, Shoulders BR, et al. Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy. JAC Antimicrob Resist. [In press]
• Sikora A, Keats K, Murphy DJ, Devlin JW, Smith SE, Murray B, Buckley MS, Rowe S, et al.; the MRC-ICU Investigator Team. A common data model for the standardization of intensive care unit (ICU) medication features in artificial intelligence (AI) applications. medRxiv 2023 Sep 18. [Epub ahead of print]
• Sikora AN, Zhang T, Murphy D, Smith SE, Murray B, Buckley MS, Rowe S, Kamaleswaran R, Chen X, Devlin JW. Machine learning vs. traditional regression analysis for fluid overload prediction in the ICU. Sci Rep 2023;13:19654.
• Alexander PMA, Aslakson RA, Barreto EF, Lee JH, Meissen H, Morrow BM, Nazer L, Branson RD, Mayer KP, Napolitano N, Lane-Fall MB, Sikora A, John PR, Dellinger RP, Parker M, Argent A, Boateng A, Green TP, Kudchadkar SR, Maslove DM, Rech MA, et al. The Reviewer Academy of the Society of Critical Care Medicine: key principles and strategic plan. Crit Care Med 2023;51:1111-23.
• Smith SE, Sikora AN, Fulford M, et al. Long-term retention of advanced cardiovascular life support knowledge and confidence in doctor of pharmacy students. Am J Pharm Educ 2024;88:100609.
• Smith ZR. Acute agitation, delirium, and sleep management. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2023 Book 2. Critical Care and Emergency Medicine. American College of Clinical Pharmacy, 2023:153-77.
• Zavala S, Kaminsky N, Roels C. Precipitation of hyponatremia and seizures by esmolol in sterile water formulation. Am J Health Syst Pharm 2024;81:e18-e20.
• Zavala S, Pape KO, Walroth TA, Reger M, Hoyte B, Thomas W, Adams B, Hill DM. Vitamin D deficiency is associated with increased length of stay after acute burn injury: a multicenter analysis. J Burn Care Res 2023 Dec 23. [Epub ahead of print]
• Elfessi ZZ, Zavala S, Rubinstein I. Presence of variable extrathoracic airflow limitation in patients with a negative methacholine challenge test. Allergy Asthma Clin Immunol 2023;19:101.

 Presentations

• Angela Slampak-Cindric:
  • Chopped: cooking up learning experiences that nourish learners without poisoning preceptors. Presented at: National Pharmacy Preceptors Conference; October 2023; virtual.
  • Simple acts of inclusion, practice advancement begins with you. Presented at: ASHP Midyear Clinical Meeting; December 2023; Las Vegas, NV.
  • Bashing BRASH: breaking the vicious cycle. Presented at: ASHP Midyear Clinical Meeting; December 2023; Las Vegas, NV.

 New ACCP Fellows

• Stephanie Bass
• Mojdeh Heavner
• Andrea Sikora
• Zach Smith
• Melissa Thompson-Bastin

 Other Notable Achievements

• Scott Bolesta: Vice Chair, ACCP Critical Care PRN Recognition Committee.
• Paige Bradshaw: Chair-Elect, ACCP Critical Care PRN Communications Committee.
• Eden Brewington:
  • BCCCP.
  • Vice Chair, ACCP Critical Care PRN Trainee Engagement Committee.

• Jenna Cox:
  • President-Elect, Carolinas/Virginias SCCM.
  • Chair, ACCP Critical Care PRN Membership Committee.

• Matt Duprey: Chair, ACCP Critical Care PRN Social Media Committee.
• Jessica Elefritz:
  • Chair, SCCM Ohio Chapter Membership Committee.
  • Fellow, American College of Critical Care Medicine (FCCM).

• Alexander Flannery: Fellow, American Society of Nephrology.
• Christy Forehand: Member-at-Large, ACCP Critical PRN.
• David Gutenschwager: BCCCP.
• Leslie Hamilton:
  • Chair, ACCP FCCP Committee.
  • ENLS Pharmacy Working Group Lead, Neurocritical Care Society.
  • Co-Chair, Neurocritical Care Society Annual Meeting.
  • Chair-Elect, Neurocritical Care Society Pharmacy Section.
  • Co-Lead, SCCM CPP Research and Scholarship Committee Charge 4.
  • Chair, TN Pharmacists Association Awards Committee.

• Ashley Hawthorne:
  • Secretary, Bay Area Health-System Pharmacists Society.
  • Ambassador Program, Board of Pharmacy Specialties.

• David Hill: Chair, ACCP Critical Care PRN Research Committee.
• Miranda Howland: Chair, ACCP Critical Care PRN Recognition Committee.
• Judith Jacobi: Past-Chair, SCCM LEAD.
• Kelli Keats: Junior Charge Lead, SCCM CPP Patient Safety Update Newsletter.
• Michael Kenes: BPS Critical Care Specialty Council.
• Rachel Klosko:
  • President, NYS ACCP.
  • President-Elect, Southern Tier Society of Health-System Pharmacists.

• Nicole Moreno: BCCCP.
• Amanda Neal: BCCCP.
• Rebecca Orr:
  • CE Coordinator-Elect, Southern Gulf Society of Health-System Pharmacists.
  • BCPS.

• Nicole Palm: Secretary/Treasurer, ACCP Critical Care PRN.
• Stacy Pasciolla: Chair, ACCP Critical Care PRN Trainee Engagement Committee.
• Kerry Anne Rambara: Chair, ACCP Critical Care PRN Travel Award Committee.
• Melissa Santibañez: Fellow, American College of Critical Care Medicine (FCCM).
• Angela Slampak-Cindric: Fellow, American College of Critical Care Medicine (FCCM).
• Susan Smith:
  • Immediate Past-Chair, AACP Women Faculty SIG.
  • Chair-Elect, SCCM Item-Writing Committee.
  • Chair, ACCP Critical Care PRN.

• Zach Smith:
  • Chair-Elect, ACCP Critical Care PRN.
  • Chair, ACCP Critical PRN Program Committee.
  • President, SCCM Michigan Chapter.

• Melissa Thompson-Bastin: Member-at-Large, ACCP Critical Care PRN.
• Lorraine Todor: BCPS.

Drug Information PRN

Promotions

• Cambrey Nguyen: Clinical Associate Professor, University of Kansas School of Pharmacy, Lawrence, KS.

Awards

• Francesca Johnson: Distinguished Young Pharmacist of the Year, Pharmacy Society of Wisconsin in August.

Publications

• Davidson SM, Brown JN, Nance CB, et al. Use of methenamine for urinary tract infection prophylaxis. Systematic review of recent evidence. Int Urogynecol J 2024 Feb 8. [Epub ahead of print]
• Nguyen CB. Improving health equity: evaluation of accessible written medication information for patients with visual impairments. J Am Pharm Assoc (2003) 2023 Jul 7. [Epub ahead of print]
• Nguyen CB. Using drug information to bridge basic science with pharmacy practice. Pharm Educ 2023;23:407-11.
• Nguyen CB, Moeller KE, McGuire M, et al. Consumer perception, knowledge, and uses of cannabidiol. Ment Health Clin 2023;13:217-24.
• O’Toole R, Martinez KA, Rothberg MD, Diiorio G, Stenehjem EA, Ward KE, et al. Antibiotics on demand: advances in asynchronous telemedicine call for increased antibiotic surveillance. Clin Infect Dis 2024;78:308-11.
• Vordenberg SE, Fusco NM, Ward KE, et al. An integrative review of micro-credentials and digital badges for pharmacy educators. Am J Pharm Educ 2024;88:100660.
• Wang S, Puggioni G, Wu J, Meador KJ, Caffrey A, Wyss R, Slaughter JL, Suzuki E, Ward KE, et al. Prenatal exposure to opioids and neurodevelopmental disorders in children: a Bayesian mediation analysis. Am J Epidemiol 2024;193:308-22.

 Other Notable Achievements

• Francesca Johnson: BCACP.

Education and Training PRN

Awards

• Paul Boylan: 2023 New Educator Award, American College of Clinical Pharmacy.
• Eliza Dy-Boarman: 2024 Hartig Distinguished Professor Award, Drake University College of Pharmacy and Health Sciences.
• Abigail Elmes:
  • Pharmacy Practice 2023 Publication of the Year Award, University of Illinois Chicago College of Pharmacy.
  • 1st Place, Poster Walk Rounds ACCP Annual Meeting, Ambulatory Care PRN.
  • 2nd Place, Outstanding Paper Award, ACCP Ambulatory Care PRN.
  • Frederick P. Siegel Innovative Teaching Award, University of Illinois Chicago College of Pharmacy.

• Alex Infante: Pharmacy Practice 2023 Publication of the Year Award, University of Illinois Chicago College of Pharmacy.
• Jennie Jarrett:
  • Pharmacy Practice 2023 Publication of the Year Award, University of Illinois Chicago College of Pharmacy.
  • 1st Place, Poster Walk Rounds ACCP Annual Meeting, Ambulatory Care PRN.
  • 2nd Place, Outstanding Paper Award, ACCP Ambulatory Care PRN.
  • Frederick P. Siegel Innovative Teaching Award, University of Illinois Chicago College of Pharmacy.

• Mary Beth O’Connell: 2024 Hall of Honor Award, Michigan Pharmacists Association.
• Jennifer Szwak: Service Award, Vizient.

 Grants

• Maya Chilbert: American College of Cardiology Foundation/Center for Disease Control and Prevention, Award Amount: $22,131, Co-Investigator.
• Abigail Elmes: University of Illinois Chicago Center for Clinical and Translational Science Pilot Implementation Grant, Award Amount: $29,968, Principal Investigator.
• Anthony Hawkins: Faculty Achievement in Classroom Teaching (FACT) Grant. University of Georgia College of Pharmacy, Award Amount: $1750, Principal Investigator.
• Mary Beth O’Connell: National Association of Boards of Pharmacy and American Association of Colleges of Pharmacy, Co-Principal Investigator.
• Ashley Woodruff: American College of Cardiology Foundation/Centers for Disease Control and Prevention, Award Amount: $22,131. Co-Investigator.

 Publications

• Meredith J, Anderson SL. Microlearning: bite-sized education for the busy healthcare professional. Almanac. September 5, 2023.
• Anthony Hawkins W, Darley A, Malcom DR, et al. Design and implementation considerations of experiential interprofessional share days for a new practitioner. Am J Health Syst Pharm 2024;81:e12-e17.
• Boylan PM. Which patients living with chronic obstructive pulmonary disease need an inhaled corticosteroid? JAAPA 2024;37:18-21.
• Boylan PM, Abdallah M, Bissell B, et al. Theophylline for the management of respiratory disorders in the 21st century: a scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network. Pharmacotherapy 2023;43:963-90.
• Boylan PM, Fleischman ME, Pinner N, et al. Respiratory syncytial virus vaccines for the prevention of lower respiratory tract infections in patients living with chronic obstructive pulmonary disease: a rapid review. Biologics (Basel) 2024;4:17-29.
• Boylan PM, Helwig KN, Gibbs MJ. Inhaled medication errors during hospitalization or on hospital discharge in patients living with chronic obstructive pulmonary disease: a literature review. Cureus 2023;15:e48631.
• Boylan PM, Knisley JJ, Wiskur B, et al. Pharmacist-social worker interprofessional relations and education in mental health: a scoping review. PeerJ 2024;12:e16977.
• Chilbert MR, Albanese N, Cieri-Hutcherson N, et al. Assessing NAPLEX preparation and impact on pass rates: a study of recent pharmacy graduates. Am J Pharm Educ 2024. [Epub ahead of print]
• Chilbert MR, Albanese N, Cieri-Hutcherson N, et al. NAPLEX preparatory perceptions from recent graduates at one college of pharmacy. Am J Pharm Educ 2024;88:100642.
• Janke KK, Dy-Boarman EA, Appiah-Num Safo AA, et al. What types of data are pharmacy education scholars using in their abstracts for poster presentations? Am J Pharm Educ 2024;88:100662.
• Bond R, Gibson CM, Talasaz AH, et al. Analysis of gender and race in pharmacy faculty administrative ranks. Am J Pharm Educ 2024;88:Article 100585.
• Hulsizer AL, Davis S, Gibson CM. Does emergency medical services blood collection shorten time to tissue plasminogen activator in ischemic stroke? J Pharm Tech 2023;39:195-8.
• Branan TN, Hawkins WA, Palmer R, et al. Translating clinical decision-making skills from a critical care pharmacy elective to the required curriculum. Am J Pharm Educ 2024;88:100599.
• Infante A, Elmes AT, Petzel Gimbar R, Neeb C, Messmer S, Jarrett JB. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement. Int J Drug Pol 2024. [Epub ahead of print]
• Isaacs AN, Buatois E, Karwa R, et al. How to phase II: timelines, perceptions, and suggestions from PGY1 residency program directors. J Am Pharm Assoc 2023;63:1106-11.
• Isaacs AN, Domingo ME, Miller ML, Beckett RD. Best practices for PGY1 letters of intent: recommendations from a modified Delphi process. Am J Health Syst Pharm 2024 Jan 23. [Epub ahead of print]
• Jarrett JB, Bratberg J, Burns, Cochran G, DiPaula BA, Dopp AL, Elmes AT, et al. Research priorities for expansion of opioid use disorder treatment in the community pharmacy. Subst Abuse 2023. [In press]
• Lingow S, Jeon M, Richter SK. Evaluation of student peer- and self-grading in an integrated pharmacotherapy course. Am J Pharm Educ 2023;87:100618.
• Noel ZR, Kulo V, Cestone C, et al. Ready or not: a crossover study of (un)graded individual readiness assurance tests in team-based learning. Am J Pharm Educ 2024;88:100670.
• O’Connell MB, Mollon L, Arif S. Culturally sensitive and equitable person-centered care. In: Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach, 3rd ed. McGraw-Hill. AccessPharmacy. 2024:eChap 2.
• O’Connell MB, Pelaccio K, Tabon P, et al. Medicare Part D Plan comparisons and switching. J Am Geriatr Soc 2024 Jan 19. [Epub ahead of print]
• O’Connell MB, Smith J, Borgelt L. Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach, 3rd ed. McGraw-Hill, 2024.
• Vernon V, Patel J, Cieri-Hutcherson NE, Arellano R, Elmore H, Griffin BL, Mitzel K, Moyeno WM, O’Connell MB, et al. The impact of COVID-19 on select considerations in patients of reproductive age: brief talking points for pharmacists. J Am Pharm Assoc 23:63:720-4.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course. 2023 ed. American College of Clinical Pharmacy, 2023:83-113.
• Richter LM, Soric MM, Hilaire ML, et al. Integrating professional identity formation into experiential pharmacy education and training. Am J Health Syst Pharm 2024;81:e48-52.
• Steuber TD, Gonzalez J, Isaacs AN, Kelley KW, Nisly SA, Szwak JA, Hong L, Howard ML. Integrating learners into research and quality improvement projects. J Am Coll Clin Pharm. [In press]
• Szwak JA, Anwar Assadi R, Gonzalez J, Hong LT, Meyenburg LK, Miesner AR, Steuber T, et al. Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists. J Am Coll Clin Pharm 2024 Jan 14. [Epub ahead of print]
• Sperry JD, Loeb A, Smith MJ, Brighton TB, Ehret JA, Fermo JD, Gentili ME, Lancaster JW, Mazur JN, Spezzano K, Szwak JA. Retrospective, multicenter, analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity. J Thromb Thrombolysis. [In press]

Presentations

• Sarah Anderson: Think again: challenging the path of least resistance. Presented at: CMEpalooza; October 18, 2023; virtual.
• Paul Boylan:
  • Contributor. Theophylline for the management of respiratory disorders in the 21st century: a scoping review from the Pulmonary Practice and Research Network – Ep 123. ACCP Journals Podcast, American College of Clinical Pharmacy, September 2023.
  • It takes two to tango: dual inhaled bronchodilators for chronic obstructive pulmonary disease. Presented at: The Walter P. Scheffe Continuing Pharmaceutical Education Series; October 2023; Oklahoma City, OK.

• Kate Cozart:
  • The art and science of compassion. Presented at: ASHP Midyear Clinical Meeting; December 2024; Anaheim, CA.
  • We DID start the fire: igniting motivation in pharmacy learners. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.

• Abigail Elmes, Alex Infante, and Jennie Jarrett:
  • Providing medication-assisted recovery via low barrier buprenorphine from a mobile medical unit in Chicago: a two-year review. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.
  • Internal medicine and emergency medicine provider perceptions of a pharmacist-driven opioid use disorder medication-assisted recovery inpatient consult service. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.
  • Pharmacist-driven inpatient opioid use disorder medication assisted recovery (OUD MAR) consult service: a year in review. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.

• Caitlin Gibson:
  • The next generation in anticoagulation: goodbye Gen-Xa, hello Gen XIa? American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • Updates in Cardiology: Last-Chance Pharmacotherapy Review Webinar. American College of Clinical Pharmacy; September 2023; virtual.

• Ellen Jones: How do I adapt the guidelines, yet individualize my patient’s care? Presented at: Hong Kong Pharmacy Conference; February 2024; Hong Kong, China.
• Sara Lingow: Weighing the options: updates on the management of persons with overweight or obesity. Endocrine and Metabolism PRN Focus Session. ACCP Annual Meeting; November 2023; Dallas, TX.
• Mate Soric: Study designs: design and application. American College of Clinical Pharmacy Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course Webinar; October 2023.
• Jennifer Szwak: Use of tele-medicine for asthma and COPD self-management among underserved populations. Presented at: CHEST; October 2023; Oahu, HI.
• Evan Williams: Pearls and pitfalls for interpreting the biomedical literature. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.

Other Notable Achievements

• Evan Williams: Named to the BPS Pharmacotherapy Specialty Council.

Emergency Medicine PRN

Awards

• Sarah Harlan: Preceptor of the Year, Baptist Memorial Hospital in Memphis, TN.
• Megan Rech:
  • Presidential Citation Award, Society of Critical Care Medicine.
  • 2025 EM Lifelong Learning and Self-Assessment (LLSA) Reading List, American Board of Emergency Medicine.
  • Most Cited Manuscript and Most Downloaded Manuscript, Journal of the American College of Clinical Pharmacy.
  • Mentor of the Year Award, ACCP Emergency Medicine Practice and Research Network.
  • Mentor of the Year Award, Pharmacy to Dose: The Critical Care Podcast.

• Kyle Weant:
  • APPE-Acute Care/General Internal Medicine Pharmacy Preceptor of the Year for the South Carolina Midlands Region.
  • ACCP EMED PRN Publication of the Year Award, ACCP Emergency Medicine Practice and Research Network.

• Lauren Wolf: Best Clinical Research Award, Society for Academic Emergency Medicine Midwest Regional Meeting in Grand Rapids, MI, for abstract “Full dose challenge of moderate, severe, and unknown beta-lactam allergies in the emergency department.”

 Grants

• Megan Rech: 2024 Emergency Medicine Foundation/AstraZeneca Research Grant Coagulation and DOAC Reversal Agent Knowledge Gaps Reversal of Factor Xa Inhibitors in Veterans with Intracranial hEmoRrhage: the XaVIER study. Amount: $149,279 (0% salary support, 30% effort) Role: Primary Investigator.
• Kyle Weant: South Carolina Research Authority, University of South Carolina, Columbia, SC, $15,000. May 2023.

 Publications

• Acquisto NM, Bodkin RB, Vabishchevich Y, et al. Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department. Allergy Asthma Proc 2023;44:283-90.
• Acquisto NM, Mosier JM, Bittner BA, et al. Clinical practice guidelines for rapid sequence intubation (RSI) in the adult critically ill patient: executive summary. Crit Care Med 2023;51:1407-10.
• Acquisto NM, Mosier JM, Bittner BA, et al. Clinical practice guidelines for rapid sequence intubation (RSI) in the adult critically ill patient. Crit Care Med 2023;51:1411-1430.
• Abu Sardaneh A, Penm J, Oliver M, Gattas D, McLachlan AJ, James C, Cella C, Aljuhani O, Acquisto NM, et al. International pharmacy survey of peripheral vasopressor infusions in critical care (INFUSE) J Crit Care 2023;78:154376.
• Bisesi SA, Stauber SD, Hutchinson DJ, Acquisto NM. Current practices and safety of medication use during pediatric rapid sequence intubation. J Pediatr Pharmacol Ther 2024;29:66-75.
• Duong A, Heacock S, Amering S, Brennan L, Venci J, Acquisto NM. Real-world impact of 3 mg and 4.5 mg doses of dulaglutide on weight and hemoglobin A1c in patients with type 2 diabetes mellitus. Ann Pharmacother 2023 Sep 24. [Epub ahead of print]
• Kamta J, Fregoso B, Lee A, Kutsuris C, Kadow E, Walker C, Sensenbach B, O’Donnell C, Porter A, Blankenberg J, Acquisto N, et al. Improving emergency medicine clinician awareness of prehospital-administered medications. Prehosp Emerg Care 2023 Jul 28. [Epub ahead of print]
• Kamta J, Maynard K, Schult R, Bell D, Acquisto NM. Evaluation of hydroxocobalamin use for the treatment of suspected cyanide toxicity secondary to smoke inhalation. Burns 2023;50:157-66.
• Schult RF, Maynard KM, Corvelli J, Rappaport S, McKinney B, Clarkson T, Wiegand T, Malcho J, Acquisto NM. Low-dose initiation of buprenorphine in hospitalized patients on full agonist opioid therapy: a retrospective observational study. J Addict Med 2023;17:685-90.
• Uttaro E, Young MR, Falvey J, Corvelli J, Acquisto NM. Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use. Transfus Apher Sci 2023;62:103759.
• Booth DY, Cherian S, Babu R, et al. Implementation of a heparin infusion calculator in the electronic health record system as a risk-mitigation strategy in a community teaching hospital emergency department. J Emerg Nurs 2024;50:36-43.
• Koo S, Hussain Y, Booth DY, et al. Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal. J Am Pharm Assoc 2024;64:395-401.
• Murphy JE, Azad A, Barreto JN, Coons EM, Coons JC, Drury AS, Goodlet KJ, Hennessey EK, Jennings D, Kane-Gill SL, Morbitzer K, Pluckrose DM, Sikand H, Weant KA. Best practices for supporting and improving pharmacy resident research and quality improvement projects. J Am Coll Clin Pharm 2024;7:75-84.
• Harlan SS, Philpott CD, Keegan SP, et al. Pharmacokinetics of levetiracetam seizure prophylaxis in severe traumatic brain injury. Ann Pharmacother 2023 Sep 30. [Epub ahead of print]
• Alrashed MA, Perona SJ, Borgstrom MC, et al. Association between antibiotic administration before discharge and emergency department length of stay for urinary tract infection: a retrospective analysis. J Am Pharm Assoc (2003) 2024 Feb 1. [Epub ahead of print]
• Smith SE, Perona S, Weingart SD. Exploration of norepinephrine dose-capping practices: report from an international, interprofessional survey of critical care clinicians. J Pharm Pract 2024 Jan 19. [Epub ahead of print]
• Rech MA. I love clinical pharmacy practice … and had to leave it. Am J Health Syst Pharm 2024 Jan 20. [Epub ahead of print]
• Rech MA, Gottlieb M. Calcium channel blockers should be first-line treatment for hemodynamically stable supraventricular tachycardia. Ann Emerg Med 2023 Dec 18. [Epub ahead of print]
• Rech MA, Gottlieb M. Prothrombin complex concentrate should be used to reverse factor Xa inhibitors in the setting of life-threatening bleeding. Ann Emerg Med 2023;82:362-3.
• Alexander PMA, Aslakson RA, Barreto EF, Lee JH, Meissen H, Morrow BM, Nazer L, Branson RD, Mayer KP, Napolitano N, Lane-Fall MB, Sikora A, John PR, Dellinger RP, Parker M, Argent A, Boateng A, Green TP, Kudchadkar SR, Maslove DM, Rech MA, et al. The Reviewer Academy of the Society of Critical Care Medicine: key principles and strategic plan. Crit Care Med 2023 Jun 21. [Epub ahead of print]
• Ball E, Rech MA. The authors respond: Ocular exposures to chemical agents. Am J Emerg Med 2024;76:262.
• Ball E, Rech MA. Accidental succinylcholine ocular exposure. Am J Emerg Med 2023;72:208-9.
• Engstrom K, Brown CS, Mattson AE, Lyons N, Rech MA. Pharmacotherapy optimization for rapid sequence intubation in the emergency department. Am J Emerg Med 2023;70:19-29.
• Kiskaddon AL, Smith MM, Gilliland F, Rech MA. Pharmacist avoidance or reductions in medical costs in critically and emergently ill pediatrics: PHARM-PEDS study. Crit Care Explor 2023;5:e0980.
• Lawson CK, Faine BA, Rech MA, Childs CA, Brown CS, Slocum GW, Acquisto NM, Ray L; EMPHARM-NET Study Group. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: a systematic review. Am J Emerg Med 2024;77:158-63.
• Robinson A, Rech MA, DeChristopher PJ, et al. Defining the optimal calcium repletion dosing in patients requiring activation of massive transfusion protocol. Am J Emerg Med 2023;70:96-100.
• Tednes P, Marquardt S, Kuhrau S, Heagler K, Rech M. Keeping it “current”: a review of treatment options for the management of supraventricular tachycardia. Ann Pharmacother 2023 Sep 24. [Epub ahead of print]
• Wang Y, Knobloch K, Lovett S, Lyons N, Rech MA. A pharmacist-driven deprescribing protocol for negative urine and sexually transmitted infection cultures in the emergency department increases antibiotic-free days. Am J Health Syst Pharm 2024;81:e83-e89.
• Weant KA, Baum RA, Hile BG, et al. Nebulized medications in the emergency department: a narrative review of non-traditional agents. Am J Health Syst Pharm 2024;81:88-105.
• Weant KA, Embertson KE, Fisher DW. A possible case of opioid-induced hypoglycemia and the potential role of naloxone. Adv Emerg Nurs J 2023;45:97-102.
• Weant KA, Gregory H. Acute hyperkalemia management in the emergency department. Adv Emerg Nurs J 2024;46:12-24.
• Weant KA, Gregory H. The potential utility of single-dose long-acting intravenous antibiotics for acute bacterial skin and skin-structure infections in the emergency department. Adv Emerg Nurs J 2023;45:177-86.
• Weant KA, Gregory H. Optimizing status epilepticus management in the emergency department: it’s about time. Adv Emerg Nurs J 2023;45:11-22.
• Bailey AM, Weant KA. Put it in the air? Nebulized opioids in the emergency department. Adv Emerg Nurs J 2023;45:260-5.
• Codeni MS, Weant KA, Neyens RR, et al. Safety and efficacy of fixed versus variable-dose prothrombin complex concentrate for emergent reversal of vitamin K antagonists: a systematic review and meta-analysis. Am J Emerg Med 2024;77:91-105.
• Gregory H, Aljadeed R, Desai D, Minhaj FS, Posen A, Rech MA, Smith AP, Weant K, et al. Recommendations for nonantidote medications needed in the emergency department during a mass casualty incident. Am J Health Syst Pharm 2023;80:779-85.

 Presentations

• Nicole Acquisto: Codes that make you tachycardic – emergent situations in special populations – pregnancy. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2023; Anaheim, CA.
• Deborah Booth:
  • Opioid pharmacology and opioid use disorder. Presented at: Atlantic Health System Collaborative; 2024; virtual.
  • Don’t go breaking my heart: calcium channel blocker and beta blocker overdose. Presented at: Atlantic Health System Cardiac Symposium; February 2024; West Orange, NJ.
  • Intersection between quality and guidelines for sepsis management. Continuing Education Presentation for Advanced Practice Nurses; December 2023; Summit, NJ.
  • Drugs of abuse. Continuing Education Presentation for Advanced Practice Nurses; August 24, 2023, and November 30, 2023; Summit, NJ.
  • Critical care infusions and titrations. Continuing Education Presentation for Advanced Practice Nurses; October 26, 2023; virtual and in person, Summit, NJ.
  • Sepsis awareness for the health care provider. Continuing Education Presentation for Sepsis Awareness Month: Sepsis Escape Room and Jeopardy; August 2023 and September 2023; Summit, NJ.
  • Augmenting your antibiotic knowledge. Continuing Education Presentation for Advanced Practice Nurses; June 2023; Summit, NJ.
  • Stroke pharmacology: treatment and secondary prevention. Continuing Education Presentation for Advanced Practice Nurses; June 2023; Summit, NJ.

• Megan Rech:
  • Intubation medications & skills station airway management airway and mechanical ventilation management for the critically ill patient. Presented at: 52nd Society of Critical Care Medicine Congress; January 2024; Phoenix, AZ.
  • Prevention and recovery from cardiovascular instability during and after airway management. Presented at: 52nd Society of Critical Care Medicine Congress; January 2024; Phoenix, AZ.
  • No to nitrofurantoin? Alkaline urine may signal nitrofurantoin resistance in patients with cystitis. Presented at: 2023 American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • The clot thickens: utility of viscoelastic testing in acutely ill patient populations. Presented at: 2023 American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2023; Anaheim, CA.

• Christina Tran: Hang ten: tenecteplase making waves in the treatment of stroke as alteplase wipes out. Presented at: Texas Tech University School of Pharmacy Live; 2023; virtual.
• Kyle Weant: Dream of the endless: updates in procedural sedation. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2023; Anaheim, CA.
• Lauren Wolf: OPEN (Opioid Prescribing Engagement Network) Naloxone Project Panel. Presented at: MEDIC (Michigan Emergency Department Improvement Collaborative) Collaborative-wide Meeting; 2023; Midland, MI.

Other Notable Achievements

• Nicole Acquisto: Graduate, 2023 ACCP Research and Scholarship Academy.
• Deborah Booth:
  • BCEMP.
  • Certified in Public Health.
  • Graduated with Master’s Degree in Public Health with concentration in Global Disaster Management, Humanitarian Aid, and Homeland Security.

• Lisa Hayes: BCEMP.
• Nathan Lian: BCEMP.
• Stephen Perona: BCEMP.
• Alyssa Robertson: BCEMP.
• Christina Tran: BCEMP.
• Lauren Wolf: BCEMP.

Endocrine and Metabolism PRN

Promotions

• Nathan A. Painter: Faculty Director for Office of Student Affairs, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.
• Sara (Mandy) Reece: Professor, PCOM Georgia School of Pharmacy.
• Jeanna Sewell: Clinical Associate Professor of Pharmacy Practice, Harrison College of Pharmacy, Auburn University.
• Christina H. Sherrill: Teaching Associate Professor, UNC Eshelman School of Pharmacy, Asheville Campus.
• Megan Wesling: Acting Chair of Department of Pharmacotherapy at the University of North Texas Health Science Center at Fort Worth.

 Awards

• Helen (Nellie) Berlie: Outstanding Reviewer, Pharmacotherapy – presented at ACCP Annual Meeting 2023.

 Grants

• Christina H. Sherrill (PI), Angelina Lim, William Swain. Development and implementation of a web-based escape room with embedded principles of pharmacist independent prescribing. PharmAlliance Early Career Researcher Award. $10,000.

 Publications

• Chilbert MR, Albanese N, Cieri-Hutcherson N, et al. NAPLEX preparatory perceptions from recent graduates at one college of pharmacy. Am J Pharm Educ 2024;88:100642.
• Moore HE, Zaya V, Burns CV, Berlie HD. Accidental once-daily use of dulaglutide: a case report. Clin Diabetes 2024 Jan 12. [Epub ahead of print]
• Goldman JD, Busch R, Miller E. Best practice perspectives on improving early detection and management of chronic kidney disease associated with type 2 diabetes in primary care. Clin Diabetes 2024 Jan 12. [Epub ahead of print]
• Goldman JD, Choi H. Teplizumab: the first treatment to delay the progression of type 1 diabetes. Clin Diabetes 2023;41:474-6.
• Giri O, Goldman JD. Donislecel: first cellular therapy to treat patients with brittle type 1 diabetes. Clin Diabetes 2023;cd230091.
• Pavlakis G, Goldman JD. Diabesity treatments today and tomorrow. Published ahead of print 10/4/23. ADCES Pract 2023;11:26-32.
• Zhang A, El Hachem R, Goldman J. Preventing and treating metabolic dysfunction-associated steatotic liver disease in people with type 2 diabetes: promising therapeutic agents and strategies. ADCES Pract 2024;12:38-42.
• Mukherjee SM, Dawson A, Carey KM. Preconception care for individuals with diabetes. EMJ 2023;11:92-101.
• Roberts G, Krinsley JS, Preiser JC, et al. The glycemic ratio is strongly and independently associated with mortality in the critically ill. J Diabetes Sci Technol 2024;18:335-44.
• Roberts G, Krinsley J, Preier JC, et al. Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio. J Crit Care 2023;77:154327.
• Roberts G, Krinsley JS, Preiser JC, et al. Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia. J Crit Care 2024;79:154429.
• Roberts G, Krinsley JS, Preiser JC, et al. Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality. J Crit Care [In press]
• Schumacher C, Chorpash A, Bolch C, Eagan K, Nimer S, Van Dril E. Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors. Pharmacotherapy 2024;44:249-57.
• Segal AR as a member of the American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. (2024) Standards of Care in Diabetes – 2024. Diabetes Care 47(suppl 1):S1-S308.
• Rittenhouse BE, Alolayan S, Eguale T, Segal AR, et al. The cost-effectiveness of metformin in the US diabetes prevention program trial: simple interpretations need not apply. Prev Med 2024;178:107819.
• Sherrill CH, Hwang AY. The pursuit of optimal semaglutide dosing in type 2 diabetes continues. Lancet 2023;402:668-9.
• Sherrill CH, Hwang AY. Use of cardioprotective antidiabetic medications in adults with and without cardiovascular disease, 2015 to March 2020. Ann Pharmacother 2024;58:248-54.
• Bickenbach E, Keegan CL, Brockel MC, Mast OG, Ghantae A, Hwang AY, Sherrill CH. Changes in metabolic parameters of hemoglobin A1c, weight, and blood pressure during and after COVID-19 stay-at-home orders in North Carolina. J Am Board Fam Med 2024 Jan 25. [Epub ahead of print]
• Bradley CL, McMillin SM, Hwang AY, Sherrill CH. Reply: Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2024 Jan 21. [Epub ahead of print]

Presentations

• Christie Schumacher
  • Advances in diabetes and cardiometabolic care. Presented at: Association of Diabetes Care and Education Specialists Live Webinar; November 9, 2023; virtual.
  • Managing chronic kidney disease in patients with diabetes. Presented at: South Piedmont Area Health Education Centers 26th Annual Procrastinators Marathon: Hot Topic Updates in Pharmacy; November 10, 2023; virtual.
  • Use of diabetes medications in the management of non-diabetes conditions. Presented at: Association of Diabetes Care and Education Specialists Live Webinar; November 17, 2023; virtual.

• Megan Wesling, Liz Van Dril. Medicare billing as universal gold standard. Presented at: Billing and Reimbursement for Patient Care Clinical Services Certificate Program through the American Society of Health-System Pharmacists; September 2023; virtual.

Other Notable Achievements

• Nathan A. Painter: Dangers of marijuana: how high-potency weed and oil can damage the teenage brain; January 24, 2024; media interview with ABC News, San Diego.
• Alissa R. Segal: Second year on American Diabetes Association’s Professional Practice Committee.

Geriatrics PRN

Publications

• Lussier ME, Gionfriddo MR, Graham JH, et al. Factors affecting prescribing of type 2 diabetes medications in older adults within an integrated healthcare system. J Gen Intern Med 2024;39:195-200.
• Hageman E, Lussier ME. Elacestrant for ER-positive HER2-negative advanced breast cancer. Ann Pharmacother 2023 Oct 27. [Epub ahead of print]
• Wisneski B, Smith E, Kaur J, Sherling S, Vanapalli S, Lussier ME. Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors used in type 2 diabetes mellitus: 2019-2023. J Manag Care Spec Pharm 2024;30:34-42.

 Awards

• Stephen Argiro: Preceptor of the Year, LIU Pharmacy/American Association of Colleges of Pharmacy.
• Linda Sobeski: Impact Award, University of Nebraska Medical Center College of Pharmacy.

Other Notable Achievements

• Stephen Argiro: Co-Chair; National Transitions of Care Coalition (NTOCC) Transitions of Care Pharmacy Committee.

GI/Liver/Nutrition PRN

Awards

• Katherine Chessman: Woman Pharmacist of the Year 2023, Health-System Pharmacy; Women Pharmacist Day, presented by Pharmacist Moms.
• Sarah Cogle: Clinical Nutrition Team of Distinction (Vanderbilt University Medical Center, Center for Human Nutrition); presented by American Society for Parenteral and Enteral Nutrition (ASPEN).
• Charles Seifert: 2023 President’s Excellence in Team Teaching Award for Clinical Toxicology, Drug Abuse, & Patient Safety, presented by Texas Tech University Health Sciences Center.

 Publications

• Chessman KH. Pediatrics: oral nutrition and rehydration of infants and children. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap e20.
• Chessman KH, Bingham A. Assessment of nutrition status and nutrition requirements. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap 164.
• Chessman KH, Haney J. Disorders of sodium and water homeostasis. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap 66.
• Cogle SV. Finding the sweet spot: managing parenteral nutrition-related glycemic complications in hospitalized adults. Nutr Clin Pract 2023;38:1263-72.
• Cogle SV, Mulherin DW, Kumpf VJ, et al. There is (patient) safety in numbers: importance of the core four in managing micronutrient deficiencies. Nutr Clin Pract 2024 Jan 15. [Epub ahead of print]
• Hill DM, Reger M, Todor LA, Cogle SV, et al. An appraisal of pharmacotherapy-pertinent literature published in 2021 and 2022 for clinicians caring for patients with thermal or inhalation injury. J Burn Care Res 2024 Jan 29. [Epub ahead of print]
• Dickerson R, Bingham A, Canada T, Lingtak C, Cober M, Cogle SV, et al. Significant published articles in 2023 for pharmacy nutrition support practice. Hosp Pharm 2024. [In press]

• Seifert CF, Mahan RJ, Mathys M, et al. An evaluation of non-academic predictors of success in a doctor of pharmacy program. Am J Pharm Educ 2023;87:Article 8924.
• Bergman E, Armstrong C, Seifert CF. Evaluating the role of intravenous antihypertensive agents in falls of hospitalized patients. J Gen Med 2023;4:1-5.
• Yang SH, Seifert CF. Evaluation of bleeding in orthopedic surgery with perioperative use of serotonergic antidepressants. Ann Pharmacother 2023;57:88591.
• Yerke JR, Mireles-Cabodevila E, Chen AY, Bass SN, et al. Peripheral administration of norepinephrine: a prospective observational study. Chest 2023;165:348-55.
• Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer C, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023;15:1226-36.

 Presentations

• Katherine Chessman: Acid/base considerations in nutrition support. Presented at: Purdue University BCSNP Recertification Program; December 2023; virtual.
• Sarah Cogle:
  • Evaluation of copper deficiency treatment in critically ill patients. Presented at: SCCM Critical Care Congress; January 2024; Phoenix, AZ.
  • Severe micronutrient deficiencies and immunodeficiency following a sleeve gastrectomy. Presented at: SCCM Critical Care Congress; January 2024; Phoenix, AZ.
  • Evaluation of parenteral nutrition order safety upon transitions of care. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.
  • Fueling the future: incorporating late-breaking lipid guidance in your ICU. Presented at: SCCM Industry Insights at SCCM Annual Congress, January 21, 2024; Phoenix, AZ.
  • Nutrition support for palliative care, hospice, and end of life. Presented at: ACCP Annual Meeting. November 13, 2023; Dallas, TX.

• Charles Seifert:
  • Ethical dilemma case discussion within interprofessional practice. Presented at: 2023 American College of Clinical Pharmacy Annual Meeting; November 14, 2023; Dallas, TX.
  • Impact of metformin on ischemic stroke events in type 2 diabetes with chronic kidney disease. Presented at: ALCALDE XXXVII Southwest Leadership Conference for Pharmacy Residents, Fellows & Preceptors; April 20, 2023; Galveston, TX.
  • Evaluation of local prescribing patterns and antimicrobial resistance in acute pyelonephritis caused by E. coli. Presented at: ALCALDE XXXVII Southwest Leadership Conference; April 20, 2023; Galveston, TX.
  • Discharge prescribing practices of naloxone for high-risk patients in the emergency department. Presented at: ALCALDE XXXVII Southwest Leadership Conference for Pharmacy Residents, Fellows & Preceptors; April 20, 2023; Galveston, TX.
  • Ethical dilemma case discussion within interprofessional practice. Presented at: Texas Interprofessional Education Consortium; April 20, 2023; Houston, TX.

Global Health PRN

Promotions

• Gina Prescott: Clinical Professor, University at Buffalo School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY.

Awards

• Martha Ndung’u: 2024 Community Engaged Scholarship Forum Partnership of Distinction. University of Pittsburgh.
• Sonak Pastakia: 2024 Immunization Champion Award, American Pharmacists Association.

 Grants

• Sonak Pastakia:
  • Creating a Model of Care to Increase Screening for Cervical Cancer Amongst Low-income women in India. Becton Dickinson. Collaborator ($150,000).
  • Peers and Technology for Adherence. National Institutes of Health. Co-Investigator ($2,500,000).

• Gina Prescott: Hypertension Management in a Community Health Clinic. University of Buffalo. Principal Investigator ($3,000).

 Publications

• Minhaj FS, Singh V, Cohen SE, et al. Prevalence of undiagnosed monkeypox virus infections during global Mpox outbreak, United States, June-September 2022. Emerg Infect Dis 2023;29:2307-14.
• O’Shea J, Zucker J, Stampfer S, Cash-Goldwasser S, Minhaj FS, et al. Prolonged mpox disease in people with advanced HIV: characterization of mpox skin lesions. J Infect Dis 2023 Nov 29. [Epub ahead of print]
• Gala P, Kamano JH, Vazquez Sanchez M, Mugo R, Orango V, Pastakia SD, et al. Cross-sectional analysis of factors associated with medication adherence in western Kenya. BMJ Open 2023;13:e072358.
• Ruhl LJ, Kiplagat J, O’Brien R, Wools-Kaloustian K, Scanlon M, Plater D, Thomas MR, Pastakia SD, et al. A Global Health Reciprocal Innovation grant programme: 5-year review with lessons learnt. BMJ Glob Health 2023;8(suppl 7):e013585.
• Prescott GM, Kanyakarun S, Thandar M. A quantitative and qualitative analysis of a medication health literacy workshop for newly and recently arrived refugees. J Am Coll Clin Pharm 2024 Jan 28. [Epub ahead of print]
• Connor S, Abrons J, Borja-Hart N, Haack S, Jonkman L, Maerten-Rivera J, Prescott GM. Engaging student pharmacists in social determinants of health and health equity through photovoice. Am J Pharm Educ 2024;88:100666.
• Li A, Lindo JF, Beckles H, Mohler JL, Reid M, Boyne M, DeHovitz J, Diaz PI, Brown P, Anzinger J, Carrington C, Anderson KB, Landay A, Cummings M, Chernyak E, Prescott G, et al. University consortium to address public health priorities and research capacity building in the Caribbean. Front Educ 2023;8:1241031.
• Lu CH, Prescott GM, Slazak EM, et al. Navigating obstacles: perspectives of US pharmacy residency directors on non-US candidates for PGY-1 residencies: a survey-based research. J Am Clin Coll Pharm 2024;7:224-33.
• Watson S, Rotundo H, Dumas J, et al. The impact of an international service-learning experience on university students’ community service attitudes. J Serv Learn Higher Educ 2024;18:113-30.

 Presentations

• Gina Prescott: Stop Diabetes Progression Initiative. Presented at: SUNY-UWI Research Consortium; December 8, 2023; Kingston, Jamaica.

Health Equity PRN

The Health Equity PRN wishes to congratulate its members on their accomplishments in the previous year. We look forward to implementing our educational, research, and mentorship initiatives. As the PRN expands, we look forward to opportunities to collaborate and more ways to engage our members. Please reach out to us if you have any questions or ideas to promote health equity in our profession.

Promotions

• Shawn Smith: Assistant Professor of Pharmacy, WesternU College of Pharmacy, Pomona, CA.

Awards

• Rena Gosser:
  • Distinguished Service Award, Section of Clinical Specialists and Scientists, American Society of Health-System Pharmacists.
  • Fellow, American Society of Health-System Pharmacists.

• Jerika Nguyen: Presidential Citation Award, Society of Critical Care Medicine.
• Mary Beth O’Connell: 2024 Hall of Honor Award, Michigan Pharmacists Association.
• Melissa Santibañez: Fellow of the American College of Critical Care Medicine, Society of Critical Care Medicine.

Grants

• Megan Fleischman: Concordia Intramural Research Grant. Concordia University Wisconsin. Principal Investigator ($4000).
• Mary Beth O’Connell: #PlanA: Through Education and Advocacy, Empower Students to Practice Safe Sex Behaviors. District IV Grant. National Association of Boards of Pharmacy and American Association of Colleges of Pharmacy. Co-Principal Investigator ($2987).
• Sharmon P. Osae: Primary Care Provider Healthcare Extension by Leveraging Pharmacists in Rural Communities Through Telehealth Technologies (PCP HELPR). President Morehead’s 2023 Interdisciplinary Seed Grant. University of Georgia. Co-Investigator ($59,502.60).
• Melissa Santibañez: Evaluating the Impact of a Training-Based Program on Social Determinants of Health as a Quality Improvement Strategy. AMCP Foundation Grant. Co-Investigator ($25,000).
• Shawn Smith: Navigation Center & Recuperative Care in a Health Provider Shortage Area. California Department of Healthcare Services – Providing Access and Transforming Health (PATH) Capacity and Infrastructure, Transition, Expansion, and Development (CITED) Round 2. Symba Center. Principal Investigator ($2,060,412.09).

Publications

• Grundman O, Allen J, Arif SA, et al. Addressing inequities in pharmaceutical education with an FIP toolkit. Pharm Educ 2023;23:560-73.
• O’Donnell P, Arif SA. Validating identities: the pharmacist’s role in providing affirming care and services to sexual and gender minority patients. Am J Health Syst Pharm 2023 Dec 29. [Epub ahead of print]
• Thomas T, Arif SA, Franklin C, et al. The intersection of professional identity formation, bias, and marginalized identities. Am J Pharm Educ 2023;87:100546.
• Boylan PM, Fleischman ME, Pinner N, Woods JA, Welch A. Respiratory syncytial virus vaccines for the prevention of lower respiratory tract infections in patients living with chronic obstructive pulmonary disease: a rapid review. Biologics (Basel) 2024;4:17-29.
• Camara E, Safri A, Ko CL, Abdul-Mutakabbir JC, et al.; on behalf of PharmGradWishlist Leadership Team. The implications of data aggregation on propagating racial and ethnic disparities within the health care landscape: actionable recommendations and considerations for pharmacists. J Am Pharm Assoc 2024;64:34-8.e1.
• O’Connell MB, Mollon L, Arif SA. Culturally sensitive and equitable patient-centered care. In: O’Connell M, Smith JA, Borgelt LM, eds. Women’s Health Across the Lifespan, 3rd ed. McGraw-Hill, 2024.
• O’Connell MB, Pelaccio K, Tabon P, et al. Medicare Part D plan comparisons and switching. J Am Geriatr Soc 2024 Jan 19. [Epub ahead of print]
• O’Connell MB, Smith J, Borgelt L. Women’s Health Across the Lifespan: A Pharmacotherapeutic Approach, 3rd. McGraw-Hill, 2024.
• Vernon V, Patel J, Cieri-Hutcherson NE, Arellano R, Elmore H, Griffin BL, Mitzel K, Moyeno WM, O’Connell MB, et al. The impact of COVID-19 on select considerations in patients of reproductive age: brief talking points for pharmacists. J Am Pharm Assoc 2023:63:720-4.
• Harris IM, Hilaire ML, Jeon M, Kier KL, Munir F, Carmon AS, Maffei MV, Mukherjee SM, Osae SP. Commentary: Pharmacists’ role in combating the medical misinformation epidemic. J Am Coll Clin Pharm 2024. [In press]
• Ali US, Hale GM, Santibañez M, et al. Is now our time? History to provider status for allied health professions and the path for pharmacists. J Am Pharm Assoc 2023;63:1515-20.
• Smith SR, Banuelos L, Trujillo N, et al. Adverse childhood experiences among California student pharmacists. Ment Health Clin 2024;14:1-9.
• Chong S, Huynh B, Wong S, Woldeyesus T, Faulks M, El-Amin K, Thibeaux J, Lewis J, Harlin R, Carter M, Shatara R, Zhou C, et al. Preferences and perspectives of Black male barbershop patrons on receiving health care in nontraditional settings. Health Equity 2023;7:835-42.

Presentations

• Sally Arif:
  • Cultivating belonging: charting the influence of social identity and bias intervention. Presented at: University of Colorado School of Pharmacy and Pharmaceutical Sciences Faculty & Staff Retreat; Winter 2024; Denver, CO.
  • Keynote Speaker: Cultivating belonging in pharmacy: navigating the “I’s” of identity, implicit bias, and inclusion. Presented at: University of Wisconsin-Madison DiveRxsity Dialogues; Fall 2023; Madison, WI.
  • Building diversity, equity, and inclusion into pharmacy residency recruitment – a replicable example. Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.

• Megan Fleischman:
  • Decoding complex CF care: simplify dosing, conquer interactions, mitigate adverse effects & unleash theratyping. Presented at: North American Cystic Fibrosis Conference; November 2023; Phoenix, AZ.
  • Severe asthma and COPD from alpha-1-antitrypsin deficiency. Presented at: ASHP Specialty Pharmacy Certificate; self-paced; virtual.

• Caroline Ko: Use of the mindful streamlining self-assessment tool for content overload. Presented at: International Teaching Learning Cooperative Lilly Conference; January 2024; San Diego, CA.
• Sharmon P. Osae: Keynote Address: Understanding social determinants of health and how they relate to pharmacy and innovation. Presented at: West Virginia Pharmacists Association 2023 Annual Meeting; October 2023; Roanoke, WV.
• Melissa Santibañez:
  • Updates in pulmonary hypertension clinical practice guidelines. Pulmonary hypertension management across the continuum of care. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
  • Evaluation of burnout rates among entry level and advanced standing students in a traditional doctor of pharmacy program. Presented at: ASHP Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • Evaluation of clinical outcomes of midodrine on intravenous vasopressor requirements in critically ill adults. Presented at: ASHP Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • Evaluating the role of sodium-glucose cotransporter-2 inhibitors in the management of acute decompensated heart failure (poster presentation). Presented at: ASHP Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • History of the Pulmonary PRN (poster presentation). Presented at: ACCP Annual Meeting; November 2023; Dallas, TX.

• Shawn Smith: Innovations in homeless healthcare: an interdisciplinary wellness approach. Presented at: APhA Hot Topics Webinar; November 2023; virtual.

Other Notable Achievements

• Caroline Ko: Invited Guest on behalf of PharmGradWishlist, Pharmacy Fika Podcast. Brock TP, Cain J, Haines ST, Janke KK (hosts). Counting What Counts – Cultivating Impactful Service in the Academy. Pharmacy Fika. February 6, 2024.

Health Outcomes PRN

Publications

• Covvey JR. Why can’t we be friends? The manufactured fear of pharmacist “scope creep.” J Am Pharm Assoc 2024;64:43-6.
• Covvey JR, Bratberg JP. Actions speak louder than words: taking a stand for reproductive healthcare and gender-affirming care. J Am Pharm Assoc 2024;64:174-8.
• Covvey JR, McClendon C, Gionfriddo MR. Back to the basics: guidance for formulating good research questions. Res Social Adm Pharm 2024;20:66-9.
• Gionfriddo MR, McClendon C, Nolfi DA, Kalarchian MA, Covvey JR. Back to the basics: guidance for designing good literature searches. Res Social Adm Pharm 2024;20:463-8.
• Gionfriddo MR, Owens K, Leist S, Schrum L, Covvey JR. Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: a systematic review. J Am Pharm Assoc 2023;63:1472-89.e3.
• Montepara CA, Bortmas MR, Cochenour CJ, Fleming MK, Gaffey SH, McQuigg MA, Parisi MK, Zimmerman DE, Covvey JR, et al. The effect of potassium supplementation and concomitant medications on potassium homeostasis for hospitalized patients. Am J Health Syst Pharm 2024;81:183-9.
• Zimmerman DE, Johnson B, Kearns A, Metro H, Robb A, Nemecek BD, Montepara CA, Covvey JR, et al. The use of buprenorphine to-go packs in the emergency department. Am J Emerg Med 2024;77:154-7.
• Zimmerman DE, Tomas M, Miller D, Tomcsanyi L, Signorella C, Montepara CA, Covvey JR, et al. Cephalosporins for the treatment of uncomplicated pyelonephritis: a systematic review. J Am Pharm Assoc 2023;63:1461-71.
• Lussier ME, Gionfriddo MR, Graham JH, et al. Factors affecting prescribing of type 2 diabetes medications in older adults within an integrated healthcare system. J Gen Intern Med 2024;39:195-200.
• Hageman E, Lussier ME. Elacestrant for ER-positive HER2-negative advanced breast cancer. Ann Pharmacother 2023 Oct 27. [Epub ahead of print]
• Wisniewski B, Smith E, Kaur J, Sherling S, Vanapalli S, Lussier ME. Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors used in type 2 diabetes mellitus: 2019-2023. J Manag Care Spec Pharm 2024;30:34-42.

Presentations

• Jordan Covvey
  • Presentation, treatment, and clinical outcomes of patients with Lyme carditis: a descriptive study. Presented at: ASHP Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • The use of buprenorphine to-go packs in the emergency department. Presented at: ACCP Annual Conference; November 2023; Dallas, TX.
  • Analysis of gabapentin adverse events and misuse reported through tweets: a feasibility study. Presented at: ACCP Annual Conference; November 2023; Dallas, TX.

• Mia Lussier: Nudging towards medication safety: behavioral economic principles to improve medication safety. Presented at: Southern Tier Chapter of the New York State Council of Health-System Pharmacists; October 10, 2023.

Hematology/Oncology PRN

Awards

• Sarah Hayes: Hematology/Oncology PRN Emerging Member Award, 2023; American College of Clinical Pharmacy.
• Don Moore: ASHP Best Practice Award: “Real-world clinical impact of an in-house dihydropyrimidine dehydrogenase (DPYD) genotyping test on fluoropyrimidine dosing and toxicity at a multisite cancer center.”
• Farah Raheem: Most Valued Professional of Advanced Practice Practitioners in Oncology. Horizon CME. November 2023.

 Publications

• Baggett R, Gatwood KS. Clinical outcomes of early defibrotide discontinuation: a single-center case series. Bone Marrow Transplant 2023;59:285-7.
• Oluwole OO, Dholaria BR, Knight TE, Jain T, Locke FL, Ramsdell L, Nikiforow S, Hashmi H, Mooney K, Bhaskar ST, Morris K, Gatwood K, et al. Chimeric antigen receptor T-cell therapy in the outpatient setting: an expert panel opinion from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 2024;30:131-42.
• Holle L, Suzuki S. Journal Club 4. Oncology: Mirvetuximab soravtansine in FRα-positive, platinum-resistant ovarian cancer. Moore KN, et al. N Engl J Med 2023;389:2162-74. Pharmaceuticals Monthly 2024;66:645-6.
• Bylyku J, Patel D, Holle L, Suzuki S. Journal Club. Oncology: Lazertinib versus gefitinib as first-line treatment in patients with EGFR-mutated advanced non–small-cell lung cancer: results from LASER301. J Clin Oncol 2023;41:4208-17. Pharmaceuticals Monthly 2023;65:3196-7.
• Cullen M, Huang, Jie Yi, Holle L, Suzuki S. Journal Club. Oncology: Treatment with niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: a phase 3 randomized clinical trial. JAMA Oncol 2023;9:1230-7. Pharmaceuticals Monthly. [In press]
• Hadfield M, Lyall V, Holle LM, et al. Updates in the treatment of non-metastatic castrate-resistant prostate cancer: the benefit of second-generation antiandrogen therapy. Ann Pharmacother 2023;57:1302-11.
• Morrison G, Holle L, Suzuki S. Journal Club 6. Oncology: Sotorasib plus panitumumab in refractory colorectal cancer with mutated KRAS G12C. Fakih MG, et al. N Engl J Med 2023;389:2125-39. Pharmaceuticals Monthly 2024;66:152-3.
• Morrison G, Holle L, Suzuki S. Journal Club. Enfortumab vedotin with or without pembrolizumab in cisplatin-ineligible patients with previously untreated locally advanced or metastatic urothelial cancer. J Clin Oncol 2023;41:4107-17. Pharmaceuticals Monthly 2023;65:2542-3.
• Su A, Holle L, Suzuki S. Journal Club 8. Oncology: A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts. Muñoz A, et al. J Clin Oncol 2023;41:2911-25. Pharmaceuticals Monthly 2023;65:2362-4.
• Moore DC, Elmes JB, Arnall JR, et al. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: a pharmacovigilance study and systematic review. Int Immunopharmacol 2024;129:111606.
• Moore DC, Elmes JB, Strassels SA, et al. Use of patient-reported outcome measures for oncology drugs receiving accelerated approval. Support Care Cancer 2023;31:602.
• Kachur E, Patel JN, Morse AL, Moore DC, Arnall JR. Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner. J Adv Pract Oncol 2023;14:520-32.
• Raheem F, et al. Metastatic ER+ breast cancer: mechanisms of resistance and future therapeutic approaches. Int J Mol Sci 2023;24:16198.
• Ziegengeist JL, Elmes JB, Strassels SA, Patel JN, Moore DC. Alpelisib-induced diabetic ketoacidosis: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and review of the literature. Clin Breast Cancer 2024 Jan 14. [Epub ahead of print]

 Presentations

• Sarah Hayes:
  • Balancing anti-cancer efficacy and cardiovascular safety: a pharmacist’s guide (2023) – Pharmacy Times Continuing Education (PTCE), 7th Annual Directions in Oncology Pharmacy CE Conference; virtual.
  • Hematology/oncology drug approvals, guideline updates, and pivotal clinical trials in 2023 (2023) – Board-Certified Oncology Pharmacy (BCOP) Session; American College of Clinical Pharmacy (ACCP) & American Society of Health-System Pharmacists (ASHP).
  • Navigating the future: starting your cardio-oncology clinic (2024) – International Cardio-Oncology Society (ICOS); virtual.

• Farah Raheem:
  • Binaytara Foundation Best of SABCS –Medical Oncology Updates [moderator]. January 2024; Scottsdale, AZ.
  • Hofherr M, Davis A, January S, Owen E, Raheem F, et al. Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522. Poster presented at: SABCS 2023; San Antonio, TX.
  • Managing immunotherapy-related adverse events: a pharmacist’s role. CEimpact; October 2023.

Other Notable Achievements

• Katie Gatwood: Incoming Chair of the ASTCT Pharmacy SIG, February 2024.
• Sarah Hayes: Preceptor and Program Developer, American College of Clinical Pharmacy (ACCP) Hematology/Oncology PRN Virtual Rotation (2023).

HIV PRN

Promotions

• Diana Nowicki: DAIDS Pharmacist of Record for HPTN/ACTG and other network clinical trials.

Publications

• Camara E, Safri A, Ko CL, Abdul-Mutakabbir JC, Bandali A, Brown BR, Astle KN, et al. The implications of data aggregation on propagating racial and ethnic disparities within the health care landscape: actionable recommendations and considerations for pharmacists. J Am Pharm Assoc 2024;64:34-38.e1.
• Morrison T, Wright W, Astle KN, et al. Exploring intersectionality of racism and sexual/gender minority health: implications for the pharmacy profession. Am J Health Syst Pharm 2023 Dec 26. [Epub ahead of print]
• Sofeso ST, Metitiri OM, Abdul-Mutakabbir JC, Childs-Kean LM, Ko CL, Brown BR, Astle KN, et al. Racial disparities in pharmacy postgraduate residency match rates and beyond: implications for clinical pharmacists. J Am Coll Clin Pharm 2023;6:562-4.
• Mercer KJ, Brizzi MB, Burhoe DN, Senn JM, Rohani R, Nowicki DN, Januszka JE, Wordlaw R, Durham SH. Expanding expedited partner therapy and HIV prophylaxis in the emergency department. Am J Health Syst Pharm 2023 Dec 23. [Epub ahead of print]
• Barfield RK, Brown ML, Albrecht B, Barber KE, Bouchard J, Carr AL, Chahine EB, Cluck D, Covington EW, Deri CR, Durham SH, et al. A baker’s dozen of top antimicrobial stewardship intervention publications in 2022. Open Forum Infect Dis 2024;11:ofad687.
• Hevia EC, Wooten L, Carr AL. Trimethoprim/sulfamethoxazole vs minocycline for the treatment of nonurinary monomicrobial Stenotrophomonas maltophilia infections in hospitalized patients. Ann Pharmacother 2023 Sep 30. [Epub ahead of print]
• Pizzuti M, Bailey P, Derrick C, Albrecht B, Carr AL, et al. Epidemiology and treatment of invasive Bartonella spp. infections in the United States. Infection 2024 Feb 1. [Epub ahead of print]
• Chastain DB, Spradlin M, Ahmad H, et al. Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults. Clin Infect Dis 2023 Sep 6. [Epub ahead of print]
• Alanazi AH, Chastain DB, Rudraraju M, et al. A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. Eur J Pharmacol 2023;960:176177.
• Henao-Martínez AF, Chastain DB, Thompson GR III. Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study. Antimicrob Agents Chemother 2023;67:e0072123.
• Januszka JE, Drwiega EN, Badowski ME. Bictegravir/emtricitabine/tenofovir alafenamide for HIV-1: what is the hidden potential of this emerging treatment? HIV AIDS (Auckl) 2023;15:705-11.
• Mills AR, Astle KN, Melin K. From ally to accomplice: a call to action for LGBTQIA+ health equity. Am J Health Syst Pharm 2023 Dec 26. [Epub ahead of print]
• Nowicki DN, Marx AH (co-primary authors), Carlson RB, Schultz KM, Sickbert-Bennett E, Weber DJ. Bacille Calmette-Guérin preparation and intravesical administration to patients with bladder cancer: risks to healthcare personnel and patients, and mitigation strategies. Infect Control Hosp Epidemiol 2023 Dec 11. [Epub ahead of print]
• Phan TC, Astle KN, Mills AR, et al. Implementation of pharmacist-centric services for sexual and gender minorities: a multi-site descriptive report. Am J Health Syst Pharm 2023 Dec 29. [Epub ahead of print]
• Rohani R, Malakismail J, Njoku E. Pharmacological and behavioral interventions to mitigate premature aging in patients with HIV. Curr HIV/AIDS Rep 2023;20:394-404.
• Rohani R, Yarnold PR, Scheetz MH, et al. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment. Antimicrob Agents Chemother 2023;67:e0072723.

Infectious Diseases PRN

Promotions

• Wes Kufel: Clinical Associate Professor of Medicine, Division of Infectious Diseases, SUNY Upstate Medical University, Syracuse, NY.
• Carlton Lee: Professor of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD.

Awards

• Wasim El Nekidy: 2023 Researcher of the Year, Cleveland Clinic, Abu Dhabi.
• Wes Kufel: 2024 Rising Star Award, Board of Pharmacy Specialties.

Grants

• Wes Kufel: 2024 New York State American College of Clinical Pharmacy Research Grant.
• Cynthia Nguyen. Center for Healthcare Delivery Science and Innovation (HDSI) Innovation Grant.

Publications

• Rizzo A, Suchindran S, Albrecht B, Metzger NL. Impact of internal medicine pharmacists on antimicrobial stewardship. J Am Coll Clin Pharm 2024 Feb 14. [Epub ahead of print]
• Barfield RK, Brown ML, Albrecht B, Barber KE, Bouchard J, Carr AL, Chahine EB, Cluck D, Covington EW, Deri CR, Durham SH, Faulkner-Fennell C, Freeman LK, Gauthier TP, Gibson GM, Green SB, Hobbs A, Jones BM, Jozefczyk CC, Marx AH, McGee EU, McKamey LJ, Musgrove R, Perez E, Slain D, Stover KR, Turner MS, White C, Bookstaver PB, Bland CM. A baker’s dozen of top antimicrobial stewardship intervention publications in 2022. Open Forum Infect Dis 2024;11:ofad687.
• Hevia EC, Wooten L, Carr AL. Trimethoprim/sulfamethoxazole vs minocycline for the treatment of nonurinary monomicrobial Stenotrophomonas maltophilia infections in hospitalized patients. Ann Pharmacother 2023 Sep 30. [Epub ahead of print]
• Alanazi AH, Chastain DB, Rudraraju M, et al. A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. Eur J Pharmacol 2023;960:176177.
• Collins CD, Dumkow LE, Kufel WD, Nguyen CT, Wager JL. ASHP/SIDP joint statement on the pharmacist’s role in antimicrobial stewardship. Am J Health Syst Pharm 2023;80:1577-81.
• Jebrin R, El Nekidy WS, Abidi E, et al. Racial differences in P2Y12 inhibitor responsiveness in patients undergoing neuro-endovascular procedures: a cohort from the Middle East. Clin Neurol Neurosurg 2024;239:108167.
• Rowe S, Green S, Albrecht B, et al. Long-term dalbavancin for suppression of gram-positive chronic left ventricular assist device infections. Open Forum Infect Dis 2023;10:ofad537.
• Kufel WD, Steele JM, Mahapatra R, et al. A five-year quasi-experimental study to evaluate the impact of empiric antibiotic order sets for antibiotic use metrics among hospitalized adult patients. Infect Control Hosp Epidemiol 2024 Jan 25. [Epub ahead of print]
• Hitchcock AM, Kufel WD, Mastro KA, et al. Lenacapavir: a novel injectable HIV-1 capsid inhibitor. Int J Antimicrob Agents 2024;63:107009.
• Hitchcock AM, Kufel WD, Seabury RW, et al. Impact of a pharmacist-conducted preoperative beta-lactam allergy assessment on perioperative cefazolin prescribing. J Pharm Pract 2023 Nov 6. [Epub ahead of print]
• Li JM, Cosler LE, Harausz EP, Myers CM, Kufel WD. Methenamine for urinary tract infection prophylaxis: a systematic review. Pharmacotherapy 2024;44:197-206.
• Nelson A, Baur JW, Lew A, Pettit NN, Nguyen CT. Rethinking perioperative antibiotic prophylaxis for low-risk head and neck procedures. Ann Otol Rhinol Laryngol 2024;133:458-61.
• Nguyen CT, Baccile R, Brown AM, Lew AK, Pisano J, Pettit NN. When is vancomycin prophylaxis necessary? Risk factors for MRSA surgical site infection. Antimicrob Steward Healthc Epidemiol 2024;4:e10.
• Pettit NN, Nguyen CT, Lew AK, et al. Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for antibiotics used for resistant gram-positive infections. Infect Control Hosp Epidemiol 2024;45:196-200.
• Pizzuti M, Bailey P, Derrick C, Albrecht B, Carr AL, Covington EW, Deri CR, Green SB, Hayes J, Hobbs ALV, Hornback KM, Keil E, Lukas JG, Seddon M, Taylor AD, Torrisi J, Bookstaver PB. Epidemiology and treatment of invasive Bartonella spp. infections in the United States. Infection 2024 Feb 1. [Epub ahead of print]
• Little JS, Coughlin C, Hsieh C, Lanza M, Huang WY, Kumar A, Dandawate T, Tucker R, Gable P, Vazquez Deida AA, Moulton-Meissner H, Stevens V, McAllister G, Ewing T, Diaz M, Glowicz J, Winkler ML, Pecora N, Kubiak DW, Pearson JC, et al. Neuroinvasive Bacillus cereus infection in immunocompromised hosts: epidemiologic investigation of 5 patients with acute myeloid leukemia. Open Forum Infect Dis 2024;11:ofae048.
• Smith DJ, Gold JAW, Chiller T, Bustamante ND, Marinissen MJ, Garcia Rodriguez G, Gonzalez Cortes VB, Molina CD, Williams S, Vazquez Deida AA, et al.; Fungal Meningitis Response Team. Update on outbreak of fungal meningitis among U.S. residents who received epidural anesthesia at two clinics in Matamoros, Mexico. Clin Infect Dis 2023 Sep 22. [Epub ahead of print]

Presentations

• Daniel Chastain: One vs. two touchdowns: changing durations in gram-negative and enterococcal bacteremia. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2023; Anaheim, CA.
• Wasim El Nekidy:
  • Antimicrobial dosing in patients utilizing extracorporeal therapies. Presented at: 3rd International Anesthesia & Acute Care Conference; October 2023; Abu Dhabi, UAE.
  • Methods of estimating kidney function for the purpose of drug dosing. Presented at: 3rd SEHA International Clinical Pharmacy Conference; September 2023; Abu Dhabi, UAE.

• Wes Kufel: Up and out! Presented at: Antimicrobial Stewardship in Transitions of Care. Premier Antimicrobial Stewardship Forum; December 2023; virtual.
• Cynthia Nguyen:
  • Let’s clean up these allergies! Optimizing antibiotic prophylaxis in surgery patients with reported beta-lactam allergies. Presented at: 10th Annual Clinical Updates in Infectious Disease; Chicago, IL.
  • Diagnostic Clinical Cases: What do I do with this test result? Presented at: IDWeek; October 2023; Boston, MA.

• Axel Vazquez-Deida: Multistate outbreak of Burkholderia stabilis infections associated with contaminated nonsterile, multi-use ultrasound gel. Presented at: Infectious Diseases Society of Argentina – Centers for Disease Control and Prevention: Study of Multicenter Outbreaks Series; October 2023; virtual.

Other Notable Achievements

• Madeline Belk: BCIDP.
• Allison Field: BCIDP.
• Maria Giannakos: Fellow, National Home Infusion Association.
• Cynthia Nguyen: Panel Appointment, IDSA Guidance on Infectious Complications Associated with Immunomodulators.
• Christina O’Connor: BCIDP.
• Pratish Patel: Fellow, Infectious Diseases Society of America.

Nephrology PRN

Promotions

• Amanda Condon Martinez: Senior Director, Pharmacy Clinical Services at FreseniusRx.
• Melanie Weltman: Research Assistant Professor, Department of Pharmacy & Therapeutics; University of Pittsburgh School of Pharmacy, Pittsburgh, PA.

 Awards

• Wasim El Nekidy: Received Researcher of the Year 2023 award – Cleveland Clinic, Abu Dhabi, UAE.

 Grants

• Joy MS, Awdishu L. Genetics of Drug-Induced Kidney Disease. Skaggs Scholar Program Grant. 7/1/23-7/1/25. UCSD Sub-Award: $68,056.

 Publications

• Alghanem SS, Al-Otaibi M, Awad A. Practices, knowledge, and attitudes of nephrologists towards prescribing and monitoring vancomycin at dialysis centers. Expert Rev Anti Infect Ther 2023;21:1011-9.
• Ashjian EJ, Clarke MN, Pogue KP. Overview of finerenone and its role in the treatment of chronic kidney disease in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2023;80:1708-21.
• Ashjian EJ, Genereaux M, Thompson AN, et al. Transitioning from points-based grading to a modified pass/fail grading approach in a simulated patient program. Am J Pharm Educ 2024;88:100645.
• Awdishu L, Joy MS. Endocytosis and nephrotoxicity – it’s a RAP! Kidney360 2023;4:572-4.
• Feist AA, Mariski M, Awdishu L, et al. Sirolimus long-term tolerability and impact on kidney function in lung transplantation: a single-center experience. Transplant Proc 2023;55:2470-7.
• Henderson M, Awdishu L, Morris GP, et al. Subtle changes in tacrolimus levels have an impact on early donor-specific antibodies in kidney transplantation. Prog Transplant 2023;33:335-40.
• Kashani KB, Awdishu L, Bagshaw SM, Barreto EF, et al. Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 2023;19:807-18.
• Kashani KB, Awdishu L, Bagshaw SM, Barreto EF, et al. Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 2023;19:807-18.
• Karimzadeh I, Barreto EF, Kellum JA, Awdishu L, et al. Moving toward a contemporary classification of drug-induced kidney disease. Crit Care 2023;27:435.
• Chen A, Kleppinger EL, Churchwell MD, et al. Examining competency-based education through the lens of implementation science. Am J Pharm Educ 2024;88:100633.
• Daugherty KK, Chen A, Churchwell MD, et al. Competency-based pharmacy education definition: what components need to be defined to implement it? Am J Pharm Educ 2024;88:100624.
• Knowles G, LaFleur G, Churchwell M. Evaluation of inpatient gabapentin and pregabalin use in hospitalized patients. J Pharm Technol 2024;40:30-6.
• Strausbaugh R. Korzec J, Mikolay J, Churchwell M. Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient. J Am Pharm Assoc (2003) 2024 Jan 23. [Epub ahead of print]
• Dyer SA, Nguyen V, Rafie S, Awdishu L. Impact of medication reconciliation by a dialysis pharmacist. Kidney360 2022;3:922-5.
• El Nekidy W, Abidi E, Nabil S, et al. The safety and effectiveness of apixaban in patients with end-stage kidney disease dialysis: a retrospective observational study. J Clin Med 2024;13:1351.
• Jebrin R, El Nekidy WS, Abidi E, et al. Racial differences in P2Y12 inhibitor responsiveness in patients undergoing neuro-endovascular procedures: a cohort from the Middle East. Clin Neurol Neurosurg 2024;239:108167.
• Yousif ZK, Koola JD, Macedo E, Cerda J, Goldstein SL, Chakravarthi R, Lewington A, Selewski D, Zappitelli M, Cruz D, Tolwani A, Joy MS, Jha V, Ramachandran R, Ostermann M, Pandya B, Acharya A, Brophy P, Ponce D, Steinke J, Bouchard J, Irarrazabal CE, Irarrazabal R, Boltansky A, Askenazi D, Kolhe N, Claure-Del Granado R, Benador N, Castledine C, Davenport A, Barratt J, Bhandari S, Riley AA, Davis TK, Farmer C, Hogarth M, Thomas M, Murray PT, Robinson-Cohen C, Nicoletti P, Vaingankar S, Mehta R, Awdishu L. Clinical characteristics and outcomes of drug-induced acute kidney injury cases. Kidney Int Rep 2023;8:2333-44.
• Lewis SJ, Alves B, Ratnam S, Churchwell MD. Stability and compatibility of intraperitoneal antimicrobials in peritoneal dialysate solutions. Perit Dial Int 2023;43:431-41.
• Nguyen T. Daprodustat – an HIF-PHI inhibitor: the first oral medication for the treatment of anemia in dialysis. J Nurse Pract 2023;19:104645.
• Nguyen T, Willett KC. Major drugs shortages: ethical dilemma in clinical practice [editorial]. Am J Ther 2023;30:e454-5.
• Nguyen T, Wong E, Cope R. Evaluating the efficacy and pharmacoeconomics of semaglutide and tirzepatide in the setting of obesity. Am J Ther 2023;30:e347-e352.
• Rong H, Chen S, Liu A, Nguyen T. Proton pump inhibitor and kidney disease: an intertwined relationship. Nephrol Nurs J 2023;50:415-20.
• Xiao D, Nguyen T. Hepcidin and iron: a double-edged sword. J Nurse Pract 2024;20:104877.
• Schwenk MH. Carboplatin dosing based upon renal function: 30+ years after Calvert. Kidney360 2024;5:271-3.

Presentations

• Mariann Churchwell, Julie Murphy. Multiple-choice question writing. Presented at: University of Toledo College of Pharmacy and Pharmaceutical Sciences Faculty Development Series; December 2023; Toledo, OH.
• Roth H, Churchwell M. Developing a mentorship program for student pharmacists. Poster presented at: 2023 American Society of Health-System Pharmacists Annual Meeting; December 2023; Anaheim, CA.
• Rowell H, Baki G, Howard MS, Reinert J, Churchwell MD. Physical compatibility of clinically used concentrations of ceftazidime-avibactam with 0.45% sodium chloride and Plasma-Lyte. Poster presented at: 2023 American Society of Health-System Pharmacists Annual Meeting; December 2023; Anaheim, CA.
• El Nekidy WS. Antimicrobial dosing in patients utilizing extracorporeal therapies. Presented at: 3rd International Anesthesia & Acute Care Conference; Abu Dhabi, UAE.
• Lewis SL, Dudley RW, Oestreich JH, Churchwell MD. Stability and compatibility of vancomycin and cefepime admixture in two conventional peritoneal dialysis solutions. Poster presented at: 2023 American College of Clinical Pharmacy Annual Meeting; November 2023; Dallas, TX.
• Amanda Condon Martinez. Deprescribing in solid organ transplant recipients with chronic kidney disease. Presented at: ACCP Annual Meeting; November 14, 2023; Dallas, TX.
• Melanie Weltman:
  • Electronic health record-based population health management to optimize care in CKD: Kidney CHAMP randomized clinical trial. Poster presented at: Kidney Week 2023, the American Society of Nephrology Annual Meeting; November 2023; Philadelphia, PA.
  • Use of guideline-recommended medication therapy in a high-risk chronic kidney disease population in the Kidney CHAMP trial. Poster presented at: Kidney Week 2023, the American Society of Nephrology Annual Meeting; November 2023; Philadelphia, PA.

Pediatrics PRN

Promotions

• Nick Fusco: Clinical Professor, Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
• Carlton Lee: Professor of Pediatrics, School of Medicine, Johns Hopkins University.

 Awards

• Kelly Bobo: Achievement Award, Pediatrics PRN, American College of Clinical Pharmacy.
• Kathy Chessman: Woman Pharmacist of the Year, Health-System Pharmacy, Women Pharmacist Day presented by Pharmacist Moms.
• Bernard Lee: Outstanding Practitioner Award, Pediatrics PRN, American College of Clinical Pharmacy.
• Pediatrics PRN: Winner, Total Dollars Raised, 2023 ACCP-PAC Challenge.
• Samie Sabet: Chair Award, Pediatrics PRN, American College of Clinical Pharmacy.

 Publications

• Wolken MJ, Larson S, Raney EC, Pogge EK, Afolabi TM, et al. Finding our voice: evaluation of goal setting using the Habits of Preceptors Rubric in terms of focus, “SMARTness,” and impact. J Contin Educ Health Prof 2023 Nov 8. [Epub ahead of print]
• Zilber S, Woleben K, Johnson SC, de Souza CFM, Boyce D, Freiert K, Boggs C, Messahel S, Burnworth MJ, Afolabi TM, et al. Leigh syndrome global patient registry: uniting patients and researchers worldwide. Orphanet J Rare Dis 2023;18:264.
• Grube PM, Autry EB, Kormelink LN, Young DC, Zobell JT, Bhakta ZN, Schadler AD, Kuhn RJ. A decade of change: the evolution of pharmacy services at U.S. cystic fibrosis centers. Pediatr Pulmonol 2024;59:652-61.
• Platt T, Kormelink LN, Autry EB, Rossoll SJ, Kuhn RJ. Assessment of long-term medication adherence with cystic fibrosis: an integrated approach. Pediatr Pulmonol 2024;59:458-64.
• Mabry WA, Lazar LF, Bobo KS, Shelton CM. Drug-induced hepatitis in an adolescent during concomitant use of azithromycin and lisdexamfetamine dimesylate. J Pediatr Pharmacol Ther 2023;28:460-4.
• Wilson GA, Bondi DS, Shah PA, Nelson A, et al. Neonatal serum gentamicin concentrations and outcomes following maternal once-daily gentamicin dosing. J Pediatr Pharmacol Ther 2023;28:316-22.
• Bradford CV, Fung MY, Wang A, Benefield EC, Bashqoy F, Neely S, Johnson PN. Delirium assessment treatment strategies in critically ill pediatric patients: a Pediatric Pharmacy Association practice-based research network survey study. J Pediatr Pharmacol Ther 2023;28:540-52.
• Bradford CV, Medina MS. Differences between clinical specialist vs faculty interviews from an applicant perspective. Am J Health Syst Pharm 2024;81:e65-68.
• Bradford CV, Miller JL, Harkin M, Chaaban H, Neely SB, Johnson PN. Melatonin use in infants admitted to intensive care units. J Pediatr Pharmacol Ther 2023;28:635-42.
• Bradford CV, Parman AM, Johnson PN, et al. Pharmacologic management of sialorrhea in neonatal and pediatric patients. J Pediatr Pharmacol Ther 2024;29:6-21.
• Chessman KH. Pediatrics: oral nutrition and rehydration of infants and children. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap e20.
• Chessman KH, Bingham A. Assessment of nutrition status and nutrition requirements. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap 164.
• Chessman KH, Haney J. Disorders of sodium and water homeostasis. In: DiPiro JT, Yee GC, Posey M, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2023:chap 66.
• Covington EW, Jasper-Trotter SL, Arnold RD, Amin R, Egbert S, Chung A. Prospective pilot study evaluating a vitamin D3 loading dose in critically ill children with vitamin D deficiency. Fundam Clin Pharmacol 2023 Nov 27. [Epub ahead of print]
• Barbieri J, Cober MP. Select micronutrients for the preterm neonate. Nutr Clin Pract 2023;38(suppl 2):S66-83.
• Mays A, Ayers P, Monczka J, Cober MP. Safety in parenteral nutrition compounding. Nutr Clin Pract 2023;38:1253-62.
• Robinson DT, Calkins KL, Chen Y, Cober MP, et al. Guidelines for parenteral nutrition in preterm infants: the American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 2023;47:830-58.
• Abdelkader S, Hartwell M, Hendrix-Dicken AD, Escala M, Condren M. Public interest in montelukast prior to and after announcement of black box warning and associations with adverse event reports. J Pediatr Pharmacol Ther 2024;29:90-2.
• Banda C, Grabois E, Deronde K, et al. Mpox in adolescent presenting with rectal bleeding. Clin Pediatr 2023;62:1155-7.
• Maerten-Rivera J, Woodruff A, Zhao Y, Fusco NM. Longitudinal assessment of pharmacy students’ collaborative practice abilities. Am J Pharm Educ 2024;88:100627.
• Vordenberg SE, Fusco NM, Ward KE, et al. An integrative review of micro-credentials and digital badges for pharmacy educators. Am J Pharm Educ 2024;88:100660.
• Huang X, Hapgood K, Allan K, Pruette C, Goswami E. Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients – a single-center experience. Pediatr Transplant 2024;28:e14611.
• Johnson PN, Parman A, Miller JL. Training the next generation of peer reviewers: steps for guiding pharmacy learners through the peer review process. Am J Health Syst Pharm 2024;81:e137-40.
• Bennett KK, Fox A, Miller JL, Neely SB, Dennis V, Johnson PN. A survey of post-graduate pharmacy residency graduates involved in a team-based research programme: involvement and confidence in research and scholarship activities. Pharm Educ 2023;23:430-9.
• Casten M, Miller JL, Neely SB, Harkin M, Johnson PN. Variability in opioid conversion calculators in critically ill children transitioning from fentanyl to hydromorphone. Am J Health Syst Pharm 2024;81:153-8.
• Chen TT, David AP, Barthelmess EK, MacBrayne CE. Letermovir for cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer 2023;70:e30608.
• Willis ZI, Oliveira CR, Abzug MJ, Anosike BI, Ardura MI, Bio LL, Boguniewicz J, Chiotos K, Downes K, Grapentine SP, Hersh AL, Heston SM, Hijano DR, Huskins WC, James SH, Jones S, Lockowitz CR, Lloyd EC, MacBrayne C, et al. Guidance for prevention and management of COVID-19 in children and adolescents: a consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. J Pediatric Infect Dis Soc 2024;13:159-85.
• Mannheim J, Kumar M, Bhagat PH, Nelson A. Assessing the concordance of MRSA carriage screening with MRSA infections. Hosp Pediatr 2024;14:84-92.
• Elias ER, Orth LE, Li A, et al. Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: a pilot study. Mol Genet Metab Rep 2023;38:101030.
• Girdwood ST, Hall M, Antoon JW, Kyler KE, Williams DJ, Shah SS, Orth LE, et al. Opportunities for pharmacogenetic testing to guide dosing of medications in youths with Medicaid. JAMA Netw Open 2024;7:e2355707.
• Parrish RH II. Multicomponent pharmacist intervention did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants [letter to the editor]. J Gen Intern Med 2024 Jan 5. [Epub ahead of print]
• Blair WO, Ellis MA, Fada M, Wiggins AA, Wolfe RC, Patel GP, Brockhaus KK, Droege M, Ebbitt LM, Kramer B, Likar E, Petrucci K, Shah S, Taylor J, Bingham P, Krabacher S, Moon J, Jean-Jacques E, Cleary RK, Eke R, Findley R, Parrish RH II; for the Enhanced Recovery Comparative Pharmacotherapy Collaborative. Effect of pharmacoprophylaxis on postoperative outcomes for elective colorectal surgery: a multi-center retrospective cohort study within an enhanced recovery after surgery framework. Healthcare 2023;11:3060.
• Powers BK, Ponder HL, Findley R, Wolfe R, Patel GP, Parrish RH II. Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and comparison of guidelines for perioperative pharmacotherapy core items. World J Surg 2024;48:509-23.
• Gaietto A, Panetta JC, Pauley JL, et al. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children’s Research Hospital. Cancer Chemother Pharmacol 2024 Feb 28.
• King MA, Cross SJ, Morton TH, Hijano DR, Greene WL, Sun Y, Tang L, Pauley JL, et al. Evaluation of continuous infusion vancomycin in a pediatric hematology/oncology population. Pediatr Infect Dis J 2024 Feb 12. [Epub ahead of print]
• Anadi I, Havrda DE, Owens-Mosby D, Shelton CM. Evaluation of academic and nonacademic factors of first-generation students transitioning to a pharmacy program. Am J Pharm Educ 2023;87:100598.
• Smith T, Mills K, Cober MP, Fenn NE, Hill C, King M, Pauley JL, Eiland L, Sierra C, Omecene NE, Novak K. Updates in the treatment of asthma in pediatrics: a review for pharmacists. Am J Health Syst Pharm 2023 Dec 26. [Epub ahead of print]
• Songer CN, Bondi DS, Oliveri LM, Jarrett JB, Ohler KH. Survey of pediatric pharmacy residency program directors and former residents on post-graduate training paths survey of pediatric post-graduate training paths. J Pediatr Pharmacol Ther 2023;28:530-9.
• Spyhalsky A, Kim SJ, Meaney CJ, Smith NM, Shah DK, Hassinger A, Fusco NM. Urinary biomarkers uNGAL and uKIM-1 as indicators of acute kidney injury in critically ill children exposed to vancomycin. Pharmacotherapy 2024;44:163-70.
• Stephens KS, Miller JL, Harkin M, Neely SB, Haws L, Johnson PN. Effect on phytonadione on correction of coagulation in pediatric patients with septic shock. J Pediatr Pharmacol Ther 2023;28:423-9.
• Ostrenga AR, Thackray J, McLearan HH, Mulieri KM, Bisaccia E, Militano O, Dupuis LL, Bernhardt MB; COG Pharmacy Discipline Steering Committee. Children’s Oncology Group’s 2023 blueprint for research: pharmacy. Pediatr Blood Cancer 2023;70(suppl 6):e30581.

 Presentations

• Deborah Bondi:
  • RSV prevention in pediatric patients. Presented at: Vizient Center for Pharmacy Practice Excellence Forum; October 2023; virtual.
  • 2023 critical care year in review. Presented at: Pediatric Pharmacy Association Webinar; December 2023; virtual.
  • Pharmacy practice in the United States. Presented at: Korean Pharmacy Student’s Association; September 2023; Seoul, South Korea.

• Kathy Chessman:
  • Acid/base considerations in nutrition support. Presented at: Purdue University BCSNP Recertification Program; December 2023; virtual.
  • Use of intrapleural alteplase in the treatment of parapneumonic effusion in children: a report of a 10-year experience. Presented at: American Society of Health-System Pharmacists, ASHP Midyear Clinical Meeting; December 2023; Anaheim, CA.
  • Walking the walk and talking the talk: an initiative to decrease ambulatory CLABSI cases. Presented at: Children’s Hospitals’ Solutions for Patient Safety Spring 2023 National Learning Session; May 2023; St. Louis, MO.

• Nick Fusco:
  • Addressing vaccine hesitancy and beliefs informed by medical misinformation: standardized patient case activity for interprofessional students. Presented at: National Forum on Best Practices to Address Health Misinformation; November 2023; Durham, NC.
  • Pediatric antibiotics stewardship. Presented at: Ages and Stages: National Association of Pediatric Nurse Practitioners New York Western Chapter Conference; March 2024; Buffalo, NY.

• Pete Johnson, et al. Detectable concentrations with inhaled tobramycin in critically ill infants and children. Presented at: Society of Critical Care Medicine’s 52nd Critical Care Congress; January 2024; Phoenix, AZ.
• Bernard Lee. Sepsis in all shapes and sizes. Presented at: SW Florida Society of Health-System Pharmacists; February 2024; virtual.
• Richard Parrish:
  • Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and synthesis of guidelines for perioperative pharmacotherapy elements. Late breaking research, American College of Clinical Pharmacy Annual Meeting; November 2023; Dallas, TX.
  • Pharmacoprophylaxis in colorectal surgery: a causal model with latent variables. Late breaking research, American College of Clinical Pharmacy Annual Meeting; November 2023; Dallas, TX.

 New ACCP Fellows

• Titilola Afolabi
• Christine Cox

 Other Notable Achievements

• Titilola Afolabi: Nominated candidate for 2024 ACCP Board of Trustees.
• Elizabeth Beckman: Chair, SCCM Clinical Pharmacy and Pharmacology Programs Committee.
• Deborah Bondi: Nominated candidate for 2024 ACCP Regent.
• Allison Chung: Nominated candidate for 2024 ACCP President-Elect.
• Richard Parrish:
  • Consultant, Perfecting Peds, LLC.
  • Member, Pharmacy Health Informatics Technology (HIT) Collaborative: Pharmacist Guidance Manual for Systems Interoperability.
  • Member, PACIO Transitions of Care Project, Centers for Medicare & Medicaid Services.

Perioperative Care PRN

Promotions

• Shinelle Green: Moffitt Cancer Center: Critical Care Pharmacy Specialist – Surgical Oncology.
• Jeff McKenzie: VCU Health: Clinical Pharmacy Specialist, Adult Trauma and Surgical Services (inpatient clinical coverage for non-ICU trauma surgery, acute general surgery, and surgical oncology service lines).
• Richard Parrish II: Perfecting Peds, LLC: Consultant.

 Awards

• Sara J. Hyland: OhioHealth Grant Medical Center We Care Reflections: Heroes Behind Heroes.

 Publications

• Dager WE. Developing precision-based multidisciplinary pharmacotherapy management plans in the critically ill. Pharmacotherapy 2023;43:1102-11.
• Dager WE, Trujillo TC, Gilbert BW. Approaches to precision-based anticoagulation management in the critically ill. Pharmacotherapy 2023;43:1221-36.
• Burnett AE, Barnes GD, Allen AL, Ansell J, Blumenstein M, Connors JM, Dager WE, et al.; Anticoagulation Forum Board of Directors. Comment on: 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023;71:3951-3.
• Nunnally ME, Dager WE, Patel H, et al. Revising the process and structure of the Society of Critical Care Medicine guidelines toward a living guideline model. Crit Care Med 2023;51:1281-4.
• Ebbitt LM, Kassel LE, McKenzie JJ, Palm BM, Smith AN. The pharmacist’s role in optimizing medication management before, during, and after minimally invasive and bariatric surgery. Am J Health Syst Pharm. [In press]
• Sano U, Jacisin T, Bente J. Implementation of pharmacist-led medication review service for Parkinson’s disease patients admitted for deep brain stimulation. Sr Care Pharm 2024;39:87-92.
• Harris T, Johnson E, Schadler A, Patel J, Fain E, Ebbitt L. A retrospective cohort study of the effect of sugammadex versus neostigmine on postoperative gastrointestinal motility in open colorectal surgical procedures. Surg Pract Sci 2024;16:100233.
• Maamari JA, Wolfe RC. Perioperative management of local anesthetic allergies. J Perianesth Nurs 2023;38:947-9.
• Beard MM, McKenzie JJ, Potter TG, et al. Evaluating risk factors for developing hypoglycemia during treatment of hyperkalemia with intravenous regular insulin. J Pharm Pract 2024 Jan 4. [Epub ahead of print]
• Parrish RH II. Multicomponent pharmacist intervention did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants [letter to the editor]. J Gen Intern Med 2024 Jan 5. [Epub ahead of print]
• Parrish RH II, Findley R. Optimal pharmacotherapy strategies for enhanced postoperative recovery in high-risk surgeries. In: Faintuch J, Faintuch S, eds. Recent Strategies in High Risk Surgery. Springer, 2024. [In press]
• MacArthur RB, Ashworth LD, Zhan K, Parrish RH II. How compounding pharmacies fill critical gaps in pediatric drug development processes: suggested regulatory changes to meet future challenges. Children 2022;9:1885.
• Quinn J, Bodenstab HM, Wu E, Parrish RH II. Medication management through collaborative practice for children with medical complexity: a prospective single center pilot study. J Pediatr Pharmacol Ther 2024. [In press]
• Blair WO, Ellis MA, Fada M, Wiggins AA, Wolfe RC, Patel GP, Brockhaus KK, Droege M, Ebbitt LM, Kramer B, Likar E, Petrucci K, Shah S, Taylor J, Bingham P, Krabacher S, Moon JH, Rogoz M, Jean-Jacques E, Cleary RK, Eke R, Findley R, Parrish RH II; Enhanced Recovery Comparative Pharmacotherapy Collaborative. Effect of pharmacoprophylaxis on postoperative outcomes in adult elective colorectal surgery: a multi-center retrospective cohort study within an enhanced recovery after surgery framework. Healthcare (Basel) 2023;11:3060.
• Wolfe RC, Portell J, Maamari JA. Pharmacologic management of postoperative urinary retention. J Perianesth Nurs 2023;38:667-70.
• Abraham J, Holzer KJ, Lenard EM, Meng A, Tellor B, Wolfe RC, et al. A perioperative mental health intervention for depressed and anxious older surgical patients: results from a feasibility study. Am J Geriatr Psychiatry 2024;32:205-19.
• Powers BK, Ponder HL, Findley R, Wolfe R, Patel GP, Parrish RH II. Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and comparison of guidelines for perioperative pharmacotherapy core items. World J Surg 2024. [In press]

 Presentations

• Dustin Carneal: Taking the pain out of acute pain management in chronic opioid users. Pharmacy Society of Wisconsin: Educational Conference; Madison, WI.
• Dustin Carneal and Kylar Crouse: Retrospective assessment of modifiable and non-modifiable patient specific factors that contribute to surgical site infections. ACCP Annual Meeting; November 13, 2023; Dallas, TX.
• William E. Dager:
  • A bridge to where? Bridging the gap in perioperative anticoagulation management. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 5, 2023; Anaheim, CA.
  • Anticoagulation forum innovations: perioperative management of antithrombotic agents. November 6, 2023.

• Molly Droege: Stop the clot: contemporary pharmacologic venous thromboembolism prophylaxis for the trauma and periprocedural patient. Presented at: ACCP Annual Meeting; November 11, 2023; Dallas, TX.
• Laura Ebbitt: Healthcare wide deployment of intranasal naloxone. Presented at: SCCM Critical Care Congress; January 21–23, 2024; Phoenix, AZ.
• Sara J. Hyland:
  • Inpatient anticoagulation cases: focus on bridging. Presented at: OSHP Annual Meeting; October 2023; Columbus, OH.
  • Maximizing resources: a community health system’s approach to pharmacy resident research and professional development. Presented at: ASHP National Pharmacy Preceptors Conference; October 2023.
  • Perioperative antimicrobial stewardship pharmacists role. Perioperative Care PRN Webinar Series.
  • Stop the clot: updates in VTE prophylaxis in orthopedic surgery and implementation of pharmacist-led services. Presented at: ACCP Annual Meeting; November 11, 2023; Dallas, TX.

• Eric Johnson: ACCP Peri PRN webinar: Optimizing perioperative surgical antimicrobial prophylaxis with the use of a penicillin allergy delabeling tool. Perioperative Care PRN Webinar Series. December 13, 2023; virtual.
• Richard Parrish II: Pharmacoprophylaxis in colorectal surgery: a causal model with latent variables. Late breaking research presented at: ACCP Annual Meeting; November 10–14, 2023; Dallas, TX.
• Richard Parrish II, Rachel Wolfe, Gourang Patel: Enhanced Recovery After Surgery (ERAS®) Society visceral surgery recommendations: a systematic review and synthesis of guidelines for perioperative pharmacotherapy elements. Late breaking research presented at: ACCP Annual Meeting; November 10–14, 2023; Dallas, TX.
• Kerilyn Petrucci: Stop the bleed: blood conservation and stewardship strategies in the acute hemorrhage surgical patient. Presented at: ACCP Annual Meeting; November 11, 2023; Dallas, TX.

• Rachel Wolfe:
  • Delivering value to your ERAS team: transparency in outcomes to drive change. American Society of Enhanced Recovery Annual Conference; September 11, 2023; Nashville, TN.
  • Evidence-based recommendations for monitoring and antagonism of neuromuscular blockade: overview of the new guidelines. ASHP Advantage Webinar. February 21, 2024.

Other Notable Achievements

• Dustin Carneal:
  • AdvocateHealth: System Lead for Perioperative Care/Surgical Order Set Governance.
  • Item Writer for ACCP Clinical Pharmacy Challenge.

• William Dager: American College of Clinical Pharmacy: 2023 Annual Meeting Planning Committee.
• Michelle Dansby: The Residency Program at Self Regional Healthcare now offers a Surgical Hybrid Rotation, providing residents with hands-on experience in the operating room, anesthesia, and perioperative care.
• Under the Direction of Sara J. Hyland, PRN Members Served as Clinical Pharmacy Advisors for the Ariadne Labs/Harvard Operating Room Crisis Checklist. Hyland SJ, Kramer B, Parrish R, Wolfe R, Carneal D, Johnson E, Lovely J, Patel G, Wood L.
• Richard Parrish II:
  • Advisory Board: Dispensary of Hope, Nashville, TN
  • Member: Pharmacy HIT Collaborative, Work Group 4, Pharmacist Manual for Systems Interoperability;
  • Member: Centers for Medicare & Medicaid Services, PACIO Transitions of Care Project.

• Perioperative Care PRN: 2023 ACCP-PAC PRN Challenge Winner. The PRN received “Highest Percentage of Participating PRN Members” award.

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN

Promotions

• Cyrine Haidar: Associate Member, St. Jude Children’s Research Hospital.
• Carlton K.K. Lee: Professor of Pediatrics, Johns Hopkins School of Medicine.
• Amanda Massmann: Lead Clinical Pharmacogenetics Pharmacist, Sanford Health.
• Samantha Socco: Senior Medical Science Liaison, Myriad Genetics.

 Grants

• Jason Karnes:
  • NIH/Office of the Director Precision Medicine for All of Us Researchers Collective (Medicina de Precision: Colectivo de Investigadores Salud para Todos) (PIs: Karnes [Contact], Moreno, Solomon, Subbian) 09/15/2023-08/31/2024.
  • NIH/National Heart, Lung, and Blood Institute Discovery of Immunogenomic Associations with Disease and Differential Risk Across Diverse Populations. In this project, we perform systematic investigation of the association of human leukocyte antigen (HLA) alleles with disease, using a two-pronged approach based on the phenome-wide association study (PheWAS) in the All of Us Research Program, a large, diverse DNA biobank coupled to electronic health records. (PIs: Karnes [Contact] and Wheeler) 09/10/2023-07/31/2025.

 Publications

• Elewa M, Alghanem SS, Al-Hashel J, et al. Population pharmacokinetics of topiramate in patients with epilepsy using nonparametric modeling. Ther Drug Monit 2023;45:797-804.
• Bertrand K, Sepulveda Y, Spiegel BJ, Best BM, et al. Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19. Pediatr Res 2024 Feb 12. [Epub ahead of print]
• Goyal NP, Mencin A, Newton KP, Durelle J, Carrier C, Ugalde-Nicalo P, Noel B, Mouton J, Vargas D, Magrez D, Tadde B, Birman P, Best BM, et al. An open label, randomized, multicenter study of elafibranor in children with nonalcoholic steatohepatitis (NASH). J Pediatr Gastroenterol Nutr 2023;77:160-5.
• Momper JD, Nikanjam M, Best BM, et al. Dolutegravir plasma protein binding and unbound concentrations during pregnancy and postpartum. J Acquir Immune Defic Syndr 2023;94:332-6.
• Rungmaitree S, Aurpibul L, Best BM, et al.; for the IMPAACT 2014 Study Team. Efficacy, safety, and tolerability of doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: results through week 96 from IMPAACT 2014. J Pediatric Infect Dis Soc 2023;12:602-9.
• Van Schalkwyk M, Bekker A, Decloedt E, Wang J, Theron G, Cotton M, Eke A, Cressey T, Shapiro D, Bacon K, Knowles K, George K, Browning R, Chakhtoura N, Rungruenthanakit K, Wiesner L, Capparelli E, Stek A, Mirochnick M, Best B. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Antimicrob Agents Chemother 2023;67:e0073723.
• Yeung CHT, Bertrand K, Best BM, et al. Cannabidiol exposure through maternal marijuana use: predictions in breastfed infants. Clin Pharmacokinet 2023;62:1611-9.
• Maillard M, Nishii R, Yang W, Hoshitsuki K, Chepyala D, Lee SHR, Nguyen JQ, Relling MV, Crews KR, Leggas M, Singh M, Suang JLY, Yeoh AEJ, Jeha S, Inaba H, Pui CH, Karol SE, Trehan A, Bhatia P, Antillon Klussmann FG, Bhojwani D, Haidar CE, et al. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations. J Natl Cancer Inst 2024 Jan 16. [Epub ahead of print]
• Pereira L, Haidar CE, Haga SB, et al. Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices. Front Pharmacol 2024;15:1355412.
• Turner AJ, Haidar CE, Yang W, Boone EC, Offer SM, Empey PE, et al. Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing. Clin Transl Sci 2024;17:e13699.
• Chan S, Tai YY, Yu Q, Tang Y, Sun W, Kelly N, Okawa S, Zhao J, Schwantes-An TH, Lacoux C, Torrino S, Al Aaraj Y, El Khoury W, Negi V, Liu M, Corey C, Belmonte F, Vargas S, Schwartz B, Bhat B, Chau B, Karnes J, et al. Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension. Sci Transl Med 2024;16:eadd2029.
• Giles JB, Rollin J, Martinez KL, Selleng K, Thiele T, Pouplard C, Sheppard JI, Heddle NM, Phillips EJ, Roden DM, Gruel Y, Warkentin TE, Greinacher A, Karnes JH. Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: a multicenter retrospective cohort study. Thromb Res 2023;229:198-208.
• Miller E, Sampson CUO, Desai AA, Karnes JH. Differential drug response in pulmonary arterial hypertension: the potential for precision medicine. Pulm Circ 2023;13:e12304.
• Venner E, Patterson K, Kalra D, Wheeler M, Chen YJ, Kalla S, Yuan B, Karnes J, et al.; on behalf of the All of Us Research Program Investigators. The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun Biol 2024;7:174.
• Massmann A, Christensen KD, Van Heukelom J, Schultz A, et al. Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. Eur J Hum Genet 2024 Feb 29. [Epub ahead of print]
• Mills SC, Massmann A. Congruence rates for pharmacogenomic noninterruptive alerts. Pharmacogenomics 2023;24:493-500.
• Preys CL, Blout Zawatsky CL, Massmann A, Van Heukelom J, Green RC, Hajek C, Hickingbotham MR, Zoltick ES, Schultz A, et al. Attitudes about pharmacogenomic testing vary by healthcare specialty. Pharmacogenomics 2023;24:539-49.
• Mohamed ME, Saqr A, Staley C, et al. Pharmacomicrobiomics: immunosuppressive drugs and microbiome interactions in transplantation. Transplantation 2024 Feb 16. [Epub ahead of print]
• Bhatt M, Peshkin BN, Kazi S, Schwartz MD, Ashai N, Swain SM, Smith DM. Pharmacogenomic testing in oncology: a health-system’s approach to identify oncology provider perspectives. Pharmacogenomics 2023;24:859-70.
• Hertz DL, Smith DM, Scott SA, Patel JN, Hicks JK. Response to the FDA decision regarding DPYD testing prior to fluoropyrimidine chemotherapy. Clin Pharmacol Ther 2023;114:768-79.
• Van Heukelom J, Morgan J, Massmann A, Jacobsen K, Petry NJ, Baye JF, Frear S, Schultz A. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system. Front Pharmacol 2023;14:1274165.

 Presentations

• Baye J, Petry N, Luzum J. Educational session. Getting to the heart of the matter: updates in cardiovascular pharmacogenomics. Presented at: American Society of Health-System Pharmacy Midyear Clinical Meeting; December 3–7, 2023; Anaheim, CA.
• Kasteleijn-Nolst Trenité DG, Reed RC. Evidence for a between-sex anti-seizure medicines (ASM) efficacy difference: males respond better than females, as evidenced by valproate suppression of EEG photoparoxysmal response. Abstract/poster presented at: 35th International Epilepsy Conference; September 2–6, 2023; Dublin, Ireland.
• Kwiatkoski JM, Reed RC, Schwartz HJ. Probing the maximal concentration post-absorption of a biopharmaceutics-classification-system-I drug: are dual factors, body posture and sex, both important? Are women and men really different? Abstract presented at: American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting; December 3–7, 2023; Anaheim, CA.
• Safko MK, Reed RC, Schwartz HJ. Caffeine eliminates the circadian variation known to occur with a biopharmaceutics-classification-system-I drug: evidence from a steady-state pharmacokinetic study in stable, hospitalized pulmonary patients. Abstract presented at: American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting; December 3–7, 2023; Anaheim, CA.

Pulmonary PRN

Promotions

• Jean Moon: Associate Dean of Student Affairs at The University of Minnesota College of Pharmacy, Minneapolis, MN.

Awards

• Paul Boylan: ACCP New Educator Award 2023.
• Jean Moon: Academies of Excellence in Clinical Practice Inductee, University of Minnesota.
• Melissa Santibañez: Fellow of the American Society of Critical Care Medicine.
• Paul Solinsky: 2023 Health System Pharmacist of the Year, Maryland Society of Health-System Pharmacists.

Grants

• Megan Fleischman: Concordia University Intramural Research Grant. Principal Investigator ($4000).
• Melissa Santibañez: Evaluating the Impact of a Training-Based Program on Social Determinants of Health as a Quality Improvement Strategy. Academy of Managed Care and Specialty Pharmacy Foundation Grant. Co-Investigator ($25,000).

Publications

• Boylan PM. Which patients living with chronic obstructive pulmonary disease need an inhaled corticosteroid? JAAPA 2024;37:18-21.
• Boylan PM, Abdallah M, Bissell B, Malesker M, Santibañez M, Smith Z. Theophylline for the management of respiratory disorders in the 21st century: a scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network. Pharmacotherapy 2023;43:963-90.
• Boylan PM, Fleischman ME, Pinner N, et al. Respiratory syncytial virus vaccines for the prevention of lower respiratory tract infections in patients living with chronic obstructive pulmonary disease: a rapid review. Biologics (Basel) 2024;4:17-29.
• Boylan PM, Helwig KN, Gibbs MJ. Inhaled medication errors during hospitalization or on hospital discharge in patients living with chronic obstructive pulmonary disease: a literature review. Cureus 2023;15:e48631.
• Boylan PM, Knisley JJ, Wiskur B, et al. Pharmacist-social worker interprofessional relations and education in mental health: a scoping review. PeerJ 2024;12:e16977.
• Lobkovich A, Javeed S, Habhab A, Hammoud R, Lipari M. Pharmacist perceptions of delivering patient care through telehealth. Am J Health Syst Pharm 2024 Jan 31. [Epub ahead of print]
• Wheeler SE, McDanel D, Kiser K, Majerczyk D, Nguyen J, Crannage E, Smith T, Lipari M. Essential elements for a nationwide remote pharmacy trainee mentoring program: an opinion of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm 2024 Jan 11. [Epub ahead of print]
• Moon JY, Westberg SM, Sorensen TD. Reconsidering the residency training pathway for ambulatory care pharmacists. J Am Pharm Assoc 2024 Jan 19. [Epub ahead of print]
• Sahlstrom Drury A, Leung JG, Witenko C, Nei S, Moon J, et al. Response to comment on gender bias in postgraduate year one pharmacy letters of recommendation. J Am Coll Clin Pharm 2023;6:1161-2.
• Ali US, Hale GM, Santibañez M, et al. Is now our time? History to provider status for allied health professions and the path for pharmacists. J Am Pharm Assoc 2023;63:1515-20.

Presentations

• Paul Boylan: It takes two to tango: dual inhaled bronchodilators for chronic obstructive pulmonary disease. Presented at: The Walter P. Scheffe Continuing Pharmaceutical Education Series; October 2023; Oklahoma City, OK.
• Megan Fleischman:
  • Decoding Complex CF Care: Simplify dosing, conquer interactions, mitigate adverse effects & unleash theratyping. Presented at: North American Cystic Fibrosis Conference; November 2023; Phoenix, AZ.
  • Severe asthma and COPD from alpha-1-antitrypsin deficiency. Presented at: ASHP’s Specialty Pharmacy Certificate; virtual.

• Jeff Gonzales: History of the Pulmonary PRN. Poster presented at: ACCP Annual Meeting; November 2023; Dallas, TX.
• Melissa Santibañez:
  • Updates in pulmonary hypertension clinical practice guidelines. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
  • Evaluation of burnout rates among entry level and advanced standing students in a traditional doctor of pharmacy program. Poster presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
  • Evaluation of clinical outcomes of midodrine on intravenous vasopressor requirements in critically ill adults. Poster presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
  • Evaluating the role of sodium-glucose cotransporter-2 inhibitors in the management of acute decompensated heart failure. Poster presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.

New ACCP Fellows

• Lori Wilken

Other Notable Achievements

• Megan Fleischman: Outline development of “Advanced Pulmonary Conditions” for ASHP’s Specialty Pharmacy Certificate.

Transplant PRN

Awards

• Kellie Goodlet: New Preceptor Award, ASHP Foundation Residency Awards.

Publications

• Jaiswal A, Kittleson M, Pillai A, Baran D, Baker WL. Usage of older donors is associated with higher mortality after transplantation: a UNOS observational study. J Heart Lung Transplant 2024 Jan 15. [Epub ahead of print]
• Diamond A, Karhadkar S, Chavin K, et al. Dosing strategies for de novo once-daily extended release tacrolimus in kidney transplant recipients based on CYP3A5 genotype. World J Transplant 2023;13:368-78.
• Kreiser M, Dupuis RE, Szempruch KR, et al. Reduced dosing versus full dosing valganciclovir for prophylaxis of cytomegalovirus in high-risk abdominal transplant recipients. Clin Transplant 2023;37:e15041.
• Murphy JE, Azad A, Barreto JN, Coons EM, Coons JC, Drury AS, Goodlet KJ, Hennessey EK, Jennings D, Kane-Gill SL, Morbitzer K, Pluckrose DM, et al. Best practices for supporting and improving pharmacy resident research and quality improvement projects. J Am Coll Clin Pharm 2024;7:75-84.
• Passerini M, Nayfeh T, Yetmar ZA, Coussement J, Goodlet KJ, et al. Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis. Clin Microbiol Infect 2024;30:170-7.
• Pearston AP, Ingemi AI, Shaeffer ZA, et al. Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL). Clin Transplant 2023;37:e15140.
• Phillips M, Rose J, Hamel A, Ingemi A. Safety and feasibility assessment of a pharmacy-driven AUC/MIC vancomycin dosing protocol in a multicenter hospital system. Microbiol Spectr 2023;11:e0331322.
• Rikard RA, Chargualaf LM, Coulter C, Weimer ET, Schmitz JL, Kotzen ES, Prom A, Toledo AH, Szempruch KR. Alemtuzumab vs anti-thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen. Clin Transplant. [In press]
• Szempruch KR, Lachiewicz AM, Williams BM, et al. Microbiological cultures and antimicrobial prophylaxis in patients undergoing total pancreatectomy with islet cell autotransplantation. Hepatobiliary Pancreat Dis Int 2023;22:426-9.
• Szempruch KR, Martschenko AD, Arora H, et al. Normal saline vs Plasma-Lyte A use intra- and post-operatively in adult kidney transplant recipients. OBM Transplant 2023;7:181.
• McIntosh T, Puerzer P, Li MT, Malat G, Sammons C, Norris M, Fallah T, Trofe-Clark J, et al. A survey of solid organ transplant recipient attitudes and concerns regarding contraception and pregnancy. Clin Transplant 2023:37:e14948.
• Roll GR, Bray RA, Cooper M, Eagar TD, Gebel HM, Vranic GM, Hitchman K, Houp J, Kamoun M, Killian J, Kim J, Kumar V, Levine M, Lovasik BP, Lunow-Luke T, Parsons F, Pattanayak V, Ranch D, Shah A, Stock PG, Timofeeva OA, Trofe-Clark J, et al. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates – a multicenter cohort. Human Immunol 2023;84:278-85.

 Presentations

• Goodlet KJ. Residency interview patient case presentations: a how-to guide for shaping and sharing a stellar case and alleviating presentation vexation. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
• Goodlet KJ, Nelson J, Wieruszewski ED, Yakubu I. Solid organ transplant GEMS for the transplant and non-transplant pharmacist. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.
• Goodlet KJ, Orsini N. Environmental hazards ahead: updates in the management of nocardiosis and nontuberculous mycobacterial infection in immunocompromised populations. Presented at: ASHP Midyear Clinical Meeting & Exhibition; December 2023; Anaheim, CA.

Other Notable Achievements

• Amanda Ingemi: Nominated to be the pharmacist representative on ISHLT’s Mechanical Circulatory Support Steering Committee.

Women’s Health PRN

Awards

• Nicole Cieri-Hutcherson: Pharmacy Practice Service Award, University at Buffalo SPPS Department of Pharmacy Practice.

Presentations

• Nicole Cieri-Hutcherson:
  • Anatomy and physiology of reproductive system and conception. Presented at: American Society of Health-System Pharmacists; January 2024; virtual.
  • Health disparities and inpatient management of obstetric emergencies. Presented at: Western New York Society of Health-System Pharmacists; October 17, 2023; Buffalo, NY.
  • Pharmacist provision of contraception and the evolution of the pharmacist’s role in reproductive healthcare. Co-presented with Sarah Lynch, Pharm.D. Presented at: New York State Chapter of the American College of Clinical Pharmacists Annual Meeting; September 30, 2023; Johnson City, NY.

Publications

• Bartelme KM. Polycystic ovary syndrome. In: O’Connell M, Smith JA, Borgelt LM, eds. Women’s Health Across the Lifespan, 3rd ed. McGraw-Hill, 2024.
• Cieri-Hutcherson NE, Marji E, Hutcherson TC. Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause. Menopause 2024 Mar 12. [Epub ahead of print]
• Chilbert M, Albanese N, Cieri-Hutcherson NE, et al. NAPLEX preparatory perceptions from recent graduates at one college of pharmacy. Am J Pharm Educ 2024;88:100642.
• Lycouras MS, Clark C, Cieri-Hutcherson NE, et al. Implementation of a pharmacist-driven chronic obstructive pulmonary disease transitions of care service at a large academic medical center. J Am Coll Clin Pharm 2024 Feb 13. [Epub ahead of print]
• Rafie S, Majerczyk D, Cieri-Hutcherson NE, Campbell N, Herman A, Stone R, Leader L, Weddendorf E, McBane S, Karaoui L, Herman A, Kaczmarski K. Pharmacist dispensing of mifepristone: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm 2023 Dec 13. [Epub ahead of print]
• Vernon V, Cieri-Hutcherson NE, Arellano R, Collins O, Lodise N. Contraception for transgender and gender diverse individuals in pharmacy education: a cross-sectional survey and select resources. Curr Pharm Teach Learn 2023;15:715-21.
• Westberg SM, Arellano R, Cieri-Hutcherson NE, Heinrich NT, Herman AM, Lodise NM, McBane S, Ofili TU, O’Grady N, Sankey KH. Pharmacotherapy of chronic neuropsychiatric conditions in the pregnant woman. Nurs Womens Health 2024;28:32023.